| Masthead |
|
|
|
|
|
|
|
|
|
| Editorial Board |
|
|
|
|
|
|
|
|
|
| Table of Contents |
|
|
|
|
|
|
|
|
|
| Table of Contents |
|
|
|
|
|
|
|
|
|
| Masthead |
|
|
|
|
|
|
|
|
|
| Addendum: Preconception and prenatal testing of biologic fathers for carrier status; Carrier screening in individuals of Ashkenazi Jewish descent; Carrier screening for spinal muscular atrophy |
|
|
|
|
|
|
✓ |
|
Ashkenazi Jewish descent |
| Addendum: Statement on informed consent for medical photographs |
|
|
|
|
|
|
|
|
|
| Editorial Board |
|
|
|
|
|
|
|
|
|
| Genetic and clinical landscape of childhood cerebellar hypoplasia and atrophy |
|
|
|
|
|
|
|
|
|
| An updated counseling framework for moderate-penetrance colorectal cancer susceptibility genes |
|
|
|
|
|
|
|
|
|
| De novo missense variants in the E3 ubiquitin ligase adaptor KLHL20 cause a developmental disorder with intellectual disability, epilepsy, and autism spectrum disorder |
|
|
|
|
|
|
|
|
|
| FOSL2 truncating variants in the last exon cause a neurodevelopmental disorder with scalp and enamel defects |
|
|
|
|
|
|
|
|
|
| A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder |
|
|
|
|
|
|
|
|
|
| Quantitative longitudinal natural history of 8 gangliosidoses—conceptual framework and baseline data of the German 8-in-1 disease registry. A cross-sectional analysis |
|
|
|
|
|
|
|
|
|
| Editorial Board |
|
|
|
|
|
|
|
|
|
| Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants |
|
|
|
|
|
|
|
|
|
| One-year results of a clinical trial of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency |
|
|
|
|
|
|
|
|
|
| HTAADVar: Aggregation and fully automated clinical interpretation of genetic variants in heritable thoracic aortic aneurysm and dissection |
|
|
|
|
|
|
|
|
|
| De novo variants are a common cause of genetic hearing loss |
|
|
|
|
|
|
|
|
|
| Estimation of the number of people with Down syndrome in Australia and New Zealand |
|
|
|
|
|
|
|
|
|
| Masthead |
|
|
|
|
|
|
|
|
|
| Table of Contents |
|
|
|
|
|
|
|
|
|
| Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions |
|
|
|
|
|
|
|
|
|
| The p190 RhoGAPs, ARHGAP35, and ARHGAP5 are implicated in GnRH neuronal development: Evidence from patients with idiopathic hypogonadotropic hypogonadism, zebrafish, and in vitro GAP activity assay |
|
|
|
|
|
|
|
|
|
| A pragmatic clinical trial of cascade testing for familial hypercholesterolemia |
|
|
|
|
|
|
|
|
|
| Response to Grosse and Gudgeon |
|
|
|
|
|
|
|
|
|
| High detection rate from genetic testing in BRCA-negative women with familial epithelial ovarian cancer |
|
|
|
|
|
|
|
|
|
| The natural history of fibrodysplasia ossificans progressiva: A prospective, global 36-month study |
|
|
|
|
|
|
|
|
|
| Genetic drivers of Cushing’s disease: Frequency and associated phenotypes |
|
|
|
|
|
|
|
|
|
| Correspondence on “Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions” by Lavelle et al |
|
|
|
|
|
|
|
|
|
| BiP inactivation due to loss of the deAMPylation function of FICD causes a motor neuron disease |
|
|
|
|
|
|
|
|
|
| Awareness and use of genetic testing: An analysis of the Health Information National Trends Survey 2020 |
|
|
|
|
|
|
|
|
|
| Response to Ramos et al |
|
|
|
|
|
|
|
|
|
| Clinical implementation of genetic testing in adults for hereditary hematologic malignancy syndromes |
|
|
|
|
|
|
|
|
|
| Functional characteristics of a broad spectrum of TBX6 variants in Mayer-Rokitansky-Küster-Hauser syndrome |
|
|
|
|
|
|
|
|
|
| Desperately seeking solutions |
|
|
|
|
|
|
|
|
|
| Growth parameters in children with achondroplasia: A 7-year, prospective, multinational, observational study |
|
|
|
|
|
|
|
|
|
| Segmental aneuploidies with 1 Mb resolution in human preimplantation blastocysts |
|
|
|
|
|
|
|
|
|
| Impact of integrating genomic data into the electronic health record on genetics care delivery |
|
|
|
|
|
|
|
|
|
| Using deep learning and electronic health records to detect Noonan syndrome in pediatric patients |
|
|
|
|
|
|
|
|
|
| Correspondence on “A gene-to-patient approach uplifts novel disease gene discovery and identifies 18 putative novel disease genes” by Seaby et al |
|
|
|
|
|
|
|
|
|
| Biallelic loss-of-function variants in RABGAP1 cause a novel neurodevelopmental syndrome |
|
|
|
|
|
|
|
|
|
| Genomic and phenotypic characterization of 404 individuals with neurodevelopmental disorders caused by CTNNB1 variants |
|
|
|
|
|
|
|
|
|
| Biallelic DAW1 variants cause a motile ciliopathy characterized by laterality defects and subtle ciliary beating abnormalities |
|
|
|
|
|
|
|
|
|
| Genome sequencing is a sensitive first-line test to diagnose individuals with intellectual disability |
|
|
|
|
|
|
|
|
|
| Polygenic risk scores and risk-stratified breast cancer screening: Familiarity and perspectives of health care professionals |
|
|
|
|
|
|
|
|
|
| Alpelisib for the treatment of PIK3CA-related head and neck lymphatic malformations and overgrowth |
|
|
|
|
|
|
|
|
|
| The mitochondrial seryl-tRNA synthetase SARS2 modifies onset in spastic paraplegia type 4 |
|
|
|
|
|
|
|
|
|
| Masthead |
|
|
|
|
|
|
|
|
|
| Table of Contents |
|
|
|
|
|
|
|
|
|
| Systematic evidence-based review: The application of noninvasive prenatal screening using cell-free DNA in general-risk pregnancies |
|
|
|
|
|
|
|
|
|
| Editorial Board |
|
|
|
|
|
|
|
|
|
| Educational considerations based on medical student use of polygenic risk information and apparent race in a simulated consultation |
|
|
|
|
|
|
|
|
|
| Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Varia |
|
|
|
|
|
|
|
|
|
| Expanding the genetic and phenotypic spectrum of ACTA2-related vasculopathies in a Dutch cohort |
|
|
|
|
|
|
|
|
|
| An accessible, relational, inclusive, and actionable (ARIA) model of genetic counseling compared with usual care: Results of a randomized controlled trial |
|
|
|
|
|
|
|
|
|
| 2022 Association of Professors of Human and Medical Genetics (APHMG) consensus–based update of the core competencies for undergraduate medical education in genetics and genomics |
|
|
|
|
|
|
|
|
|
| Considerations for policymakers for improving health care through telegenetics: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG) |
|
|
|
|
|
|
|
|
|
| Heterozygous loss-of-function variants in LHX8 cause female infertility characterized by oocyte maturation arrest |
|
|
|
|
|
|
|
|
|
| Medical genetics education for pediatrics residents: A brief report |
|
|
|
|
|
|
|
|
|
| A homozygous MED11 C-terminal variant causes a lethal neurodegenerative disease |
|
|
|
|
|
|
|
|
|
| Heterozygous UCHL1 loss-of-function variants cause a neurodegenerative disorder with spasticity, ataxia, neuropathy, and optic atrophy |
|
|
|
|
|
|
|
|
|
| Evaluating perinatal and neonatal outcomes among children with vascular Ehlers–Danlos syndrome |
|
|
|
|
|
|
|
|
|
| The ClinGen Brain Malformation Variant Curation Expert Panel: Rules for somatic variants in AKT3, MTOR, PIK3CA, and PIK3R2 |
|
|
|
|
|
|
|
|
|
| A validation of models for prediction of pathogenic variants in mismatch repair genes |
|
|
|
|
|
|
|
|
|
| Genomic tools for health: Secondary findings as findings to be shared |
|
|
|
|
|
|
|
|
|
| Heterozygous variants in MYH10 associated with neurodevelopmental disorders and congenital anomalies with evidence for primary cilia-dependent defects in Hedgehog signaling |
|
|
|
|
|
|
|
|
|
| Discovering monogenic patients with a confirmed molecular diagnosis in millions of clinical notes with MonoMiner |
|
|
|
|
|
|
|
|
|
| Biallelic variants in ADAMTS15 cause a novel form of distal arthrogryposis |
|
|
|
|
|
|
|
|
|
| Safety and preliminary efficacy on cognitive performance and adaptive functionality of epigallocatechin gallate (EGCG) in children with Down syndrome. A randomized phase Ib clinical trial (PERSEUS stu |
|
|
|
|
|
|
|
|
|
| Factors associated with the time to complete clinical exome sequencing in a pediatric patient population |
|
|
|
|
|
|
|
|
|
| Pathogenic variants in arteriopathy genes detected in a targeted sequencing study: Penetrance and 1-year outcomes after return of results |
|
|
|
|
|
|
|
|
|
| Use of eConsult to enhance genetics service delivery in primary care: A multimethod study |
|
|
|
|
|
|
|
|
|
| Preferences for a polygenic test to estimate cancer risk in a general Australian population |
|
|
|
|
|
|
|
|
|
| Table of Contents |
|
|
|
|
|
|
|
|
|
| eP384: Clinical, epidemiological and genetic characteristics of children diagnosed with Multisystem Inflammatory Syndrome (MIS-C) in Kuwait |
|
|
|
|
|
|
|
|
|
| Editorial Board |
|
|
|
|
|
|
|
|
|
| Masthead |
|
|
|
|
|
|
|
|
|
| Correspondence on “Variants in MED12L, encoding a subunit of the mediator kinase module, are responsible for intellectual disability associated with transcriptional defect” by Nizon et al |
|
|
|
|
|
|
|
|
|
| Estimating diagnostic noise in panel-based genomic analysis |
|
|
|
|
|
|
|
|
|
| Response to Kossmann Ferraz et al |
|
|
|
|
|
|
|
|
|
| Universal screening for familial hypercholesterolemia in 2 populations |
|
|
|
|
|
|
|
|
|
| De Novo ZMYND8 variants result in an autosomal dominant neurodevelopmental disorder with cardiac malformations |
|
|
|
|
|
|
|
|
|
| CFTR genotype analysis of Asians in international registries highlights disparities in the diagnosis and treatment of Asian patients with cystic fibrosis |
|
|
|
|
|
|
|
|
|
| Cost-effectiveness frameworks for comparing genome and exome sequencing versus conventional diagnostic pathways: A scoping review and recommended methods |
|
|
|
|
|
|
|
|
|
| Missense variants in ANKRD11 cause KBG syndrome by impairment of stability or transcriptional activity of the encoded protein |
|
|
|
|
|
|
|
|
|
| Genetic counseling for prion disease: Updates and best practices |
|
|
|
|
|
|
|
|
|
| The predicted effect and cost-effectiveness of tailoring colonoscopic surveillance according to mismatch repair gene in patients with Lynch syndrome |
|
|
|
|
|
|
|
|
|
| Response to Mehta et al |
|
|
|
|
|
|
|
|
|
| Correspondence on “Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consorti |
|
|
|
|
|
|
|
|
|
| OP049: Automated isolation and genetic characterization of single circulating fetal trophoblasts in pregnant women |
|
|
|
|
|
|
|
|
|
| Masthead |
|
|
|
|
|
|
|
|
|
| Table of Contents |
|
|
|
|
|
|
|
|
|
| Editorial Board |
|
|
|
|
|
|
|
|
|
| Challenges of variant reinterpretation: Opinions of stakeholders and need for guidelines |
|
|
|
|
|
|
|
|
|
| ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG) |
|
|
|
|
|
|
|
|
|
| Neurofibromatosis type 1: A comparison of the 1997 NIH and the 2021 revised diagnostic criteria in 75 children and adolescents |
|
|
|
|
|
|
|
|
|
| A scoping review of interventions increasing screening and diagnosis of familial hypercholesterolemia |
|
|
|
|
|
|
|
|
|
| Development and evaluation of polygenic risk scores for prediction of endometrial cancer risk in European women |
|
|
|
|
✓ |
|
|
|
European women |
| Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation |
|
|
|
|
|
|
|
|
|
| Rare pathogenic variants in WNK3 cause X-linked intellectual disability |
|
|
|
|
|
|
|
|
|
| Detection and characterization of male sex chromosome abnormalities in the UK Biobank study |
|
|
|
|
|
|
|
|
|
| Alternative splicing of BUD13 determines the severity of a developmental disorder with lipodystrophy and progeroid features |
|
|
|
|
|
|
|
|
|
| Reclassification of clinically-detected sequence variants: Framework for genetic clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group UK) |
|
|
|
|
|
|
|
|
|
| The views of people with a lived experience of deafness and the general public regarding genetic testing for deafness in the reproductive setting: A systematic review |
|
|
|
|
|
|
|
|
|
| Pubertal growth in osteogenesis imperfecta caused by pathogenic variants in COL1A1/COL1A2 |
|
|
|
|
|
|
|
|
|
| Challenges for precision public health communication in the era of genomic medicine |
|
|
|
|
|
|
|
|
|
| Frequency of truncating FLCN variants and Birt-Hogg-Dubé–associated phenotypes in a health care system population |
|
|
|
|
|
|
|
|
|
| The effect of rapid exome sequencing on downstream health care utilization for infants with suspected genetic disorders in an intensive care unit |
|
|
|
|
|
|
|
|
|
| Cancer Risk C (CR-C), a functional genomics test is a sensitive and rapid test for germline mismatch repair deficiency |
|
|
|
|
|
|
|
|
|
| Clinical validity assessment of genes frequently tested on intellectual disability/autism sequencing panels |
|
|
|
|
|
|
|
|
|
| Editorial Board |
|
|
|
|
|
|
|
|
|
| Masthead |
|
|
|
|
|
|
|
|
|
| Table of Contents |
|
|
|
|
|
|
|
|
|
| “Doctors shouldn’t have to cheat the system”: Clinicians’ real-world experiences of the utility of genomic sequencing |
|
|
|
|
|
|
|
|
|
| Scoping review and classification of deep learning in medical genetics |
|
|
|
|
|
|
|
|
|
| Systematic evidence-based review: The application of noninvasive prenatal screening using cell-free DNA in general-risk pregnancies |
|
|
|
|
|
|
|
|
|
| Long-term open-label phase I/II extension study of intrathecal idursulfase-IT in the treatment of neuronopathic mucopolysaccharidosis II |
|
|
|
|
|
|
|
|
|
| Pregnant Latinas’ views of adopting exome sequencing into newborn screening: A qualitative study |
|
|
|
|
|
|
|
|
|
| A nationally agreed cross-professional competency framework to facilitate genomic testing |
|
|
|
|
|
|
|
|
|
| Monoallelic and biallelic variants in LEF1 are associated with a new syndrome combining ectodermal dysplasia and limb malformations caused by altered WNT signaling |
|
|
|
|
|
|
|
|
|
| Discovering a new part of the phenotypic spectrum of Coffin-Siris syndrome in a fetal cohort |
|
|
|
|
|
|
|
|
|
| Loss-of-function variants in SRRM2 cause a neurodevelopmental disorder |
|
|
|
|
|
|
|
|
|
| Recommendations for next generation sequencing data reanalysis of unsolved cases with suspected Mendelian disorders: A systematic review and meta-analysis |
|
|
|
|
|
|
|
|
|
| Can polygenic risk scores contribute to cost-effective cancer screening? A systematic review |
|
|
|
|
|
|
|
|
|
| The current state of adult metabolic medicine in the United States: Results of a nationwide survey |
|
|
|
|
|
|
|
|
|
| Clinical evaluation and etiologic diagnosis of hearing loss: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG) |
|
|
|
|
|
|
|
|
|
| Neurologic and neurodevelopmental complications in cardiofaciocutaneous syndrome are associated with genotype: A multinational cohort study |
|
|
|
|
|
|
|
|
|
| A gene-to-patient approach uplifts novel disease gene discovery and identifies 18 putative novel disease genes |
|
|
|
|
|
|
|
|
|
| Germline rare variants of lectin pathway genes predispose to asymptomatic SARS-CoV-2 infection in elderly individuals |
|
|
|
|
|
|
|
|
|
| The Gene Curation Coalition: A global effort to harmonize gene–disease evidence resources |
|
|
|
|
|
|
|
|
|
| Table of Contents |
|
|
|
|
|
|
|
|
|
| Editorial Board |
|
|
|
|
|
|
|
|
|
| Masthead |
|
|
|
|
|
|
|
|
|
| ORCA, a values-based decision aid for selecting additional findings from genomic sequencing in adults: Efficacy results from a randomized trial |
|
|
|
|
|
|
|
|
|
| Making BRCA1 genetic test reports easier to understand through user-centered design: A randomized trial |
|
|
|
|
|
|
|
|
|
| De novo variants in the PABP domain of PABPC1 lead to developmental delay |
|
|
|
|
|
|
|
|
|
| Efficacy and safety of empagliflozin in glycogen storage disease type Ib: Data from an international questionnaire |
|
|
|
|
|
|
|
|
|
| High-affinity FcγRIIIa genetic variants and potent NK cell-mediated antibody-dependent cellular cytotoxicity (ADCC) responses contributing to severe COVID-19 |
|
|
|
|
|
|
|
|
|
| Heterozygous variants in CTR9, which encodes a major component of the PAF1 complex, are associated with a neurodevelopmental disorder |
|
|
|
|
|
|
|
|
|
| Identification of autosomal recessive novel genes and retinal phenotypes in members of the solute carrier (SLC) superfamily |
|
|
|
|
|
|
|
|
|
| A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder |
|
|
|
|
|
|
|
|
|
| Health equity in the implementation of genomics and precision medicine: A public health imperative |
|
|
|
|
|
|
|
|
|
| A randomized, placebo-controlled clinical trial evaluating olipudase alfa enzyme replacement therapy for chronic acid sphingomyelinase deficiency (ASMD) in adults: One-year results |
|
|
|
|
|
|
|
|
|
| Improving racial diversity in the genomics workforce: An examination of challenges and opportunities |
|
|
|
|
|
|
|
|
|
| Polygenic risk score as a possible tool for identifying familial monogenic causes of complex diseases |
|
|
|
|
|
|
|
|
|
| Structured approaches to implementation of clinical genomics: A scoping review |
|
|
|
|
|
|
|
|
|
| The Clinical Variant Analysis Tool: Analyzing the evidence supporting reported genomic variation in clinical practice |
|
|
|
|
|
|
|
|
|
| TTR variants in patients with dilated cardiomyopathy: An investigation of the DCM Precision Medicine Study |
|
|
|
|
|
|
|
|
|
| Breast cancer risk stratification in women of screening age: Incremental effects of adding mammographic density, polygenic risk, and a gene panel |
|
|
|
|
|
|
|
|
|
| A clinical scoring system for early onset (neonatal) Marfan syndrome |
|
|
|
|
|
|
|
|
|
| Age of first cancer diagnosis and survival in Bloom syndrome |
|
|
|
|
|
|
|
|
|
| Real world outcomes and implementation pathways of exome sequencing in an adult genetic department |
|
|
|
|
|
|
|
|
|
| Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions |
|
|
|
|
|
|
|
|
|
| Evaluating breast cancer predisposition genes in women of African ancestry |
|
|
|
|
|
|
✓ |
|
women of African ancestry |
| Perspectives and preferences regarding genomic secondary findings in underrepresented prenatal and pediatric populations: A mixed-methods approach |
|
|
|
|
|
|
|
|
|
| Table of Contents |
|
|
|
|
|
|
|
|
|
| Perspectives of diverse Spanish- and English-speaking patients on the clinical use of polygenic risk scores |
|
|
|
|
|
|
|
|
|
| Editorial Board |
|
|
|
|
|
|
|
|
|
| Masthead |
|
|
|
|
|
|
|
|
|
| Germline variants in HEY2 functional domains lead to congenital heart defects and thoracic aortic aneurysms |
|
|
|
|
|
|
|
|
|
| PPA2-associated sudden cardiac death: extending the clinical and allelic spectrum in 20 new families |
|
|
|
|
|
|
|
|
|
| Clinical impact and cost-effectiveness of a 176-condition expanded carrier screen |
|
|
|
|
|
|
|
|
|
| The morbid genome of ciliopathies: an update |
|
|
|
|
|
|
|
|
|
| A systematic review of the methodological quality of economic evaluations in genetic screening and testing for monogenic disorders |
|
|
|
|
|
|
|
|
|
| Interventions to improve delivery of cancer genetics services in the United States: A scoping review |
|
|
|
|
|
|
|
|
|
| The patient with 41 reports: Analysis of laboratory exome sequencing reporting of a “virtual patient” |
|
|
|
|
|
|
|
|
|
| Prevalence and prediction of medical distrust in a diverse medical genomic research sample |
|
|
|
|
|
|
|
|
|
| Inherited variants in CHD3 show variable expressivity in Snijders Blok-Campeau syndrome |
|
|
|
|
|
|
|
|
|
| Early age of onset and broad cancer spectrum persist in MSH6- and PMS2-associated Lynch syndrome |
|
|
|
|
|
|
|
|
|
| Online interactive genetics education during internal medicine clinical clerkship |
|
|
|
|
|
|
|
|
|
| Integrating clinical genetics in cardiology: Current practices and recommendations for education |
|
|
|
|
|
|
|
|
|
| Impact of returning unsolicited genomic results to nongenetic health care providers in the eMERGE III Network |
|
|
|
|
|
|
|
|
|
| SOX11 variants cause a neurodevelopmental disorder with infrequent ocular malformations and hypogonadotropic hypogonadism and with distinct DNA methylation profile |
|
|
|
|
|
|
|
|
|
| A longitudinal perspective of hormone replacement therapies (HRTs) on neuromotor capabilities in males with 47,XXY (Klinefelter syndrome) |
|
|
|
|
|
|
|
|
|
| ClinGen’s Pediatric Actionability Working Group: Clinical actionability of secondary findings from genome-scale sequencing in children and adolescents |
|
|
|
|
|
|
|
|
|
| A review of normative documents on preimplantation genetic testing: Recommendations for PGT-P |
|
|
|
|
|
|
|
|
|
| CLEC3B is a novel causative gene for macular-retinal dystrophy |
|
|
|
|
|
|
|
|
|
| eP140: A novel, double-blind placebo-controlled seamless phase 1/2/3 AAV9 gene therapy study for Wilson disease |
|
|
|
|
|
|
|
|
|
| eP187: Decentralization of clinical trials in the era of COVID-19: Implications for rare disease trials |
|
|
|
|
|
|
|
|
|
| eP083: Chromosomal microarray analysis as a supplement to exome sequencing in pediatric patients with suspected inborn errors of immunity |
|
|
|
|
|
|
|
|
|
| eP234: SERPINA1 sequencing facilitates detection of undiagnosed Alpha-1 antitrypsin deficiency |
|
|
|
|
|
|
|
|
|
| OP011: Physician recommendations after germline sequencing in pediatric cancer patients: Texas KidsCanSeq study |
|
|
|
|
|
|
|
|
|
| OP018: ASPIRO gene therapy trial in X-Linked Myotubular Myopathy (XLMTM): Update on preliminary efficacy and safety findings |
|
|
|
|
|
|
|
|
|
| eP009: Identification of a novel exonic deletion in the GALNS gene causing Morquio syndrome |
|
|
|
|
|
|
|
|
|
| eP015: COQ5 compound heterozygous variants in a family with global developmental delay, seizures, spastic paraparesis, and stroke |
|
|
|
|
|
|
|
|
|
| eP016: Biochemical diagnosis of pterin defect after negative broad genetic evaluation |
|
|
|
|
|
|
|
|
|
| eP024: Metabolomic mapping of rhizomelic chondrodysplasia punctata |
|
|
|
|
|
|
|
|
|
| eP025: Novel phenotype of aortic root dilatation and late onset of metabolic decompensation in patient with TMEM70 deficiency |
|
|
|
|
|
|
|
|
|
| eP034: Novel use of global untargeted metabolomics in a patient with glycogen storage disease Ib receiving off label empagliflozin treatment |
|
|
|
|
|
|
|
|
|
| eP038: A new biochemical assay to measure plasmalogens with CLIR disease differentiation |
|
|
|
|
|
|
|
|
|
| eP041: How long will they wait? Applying updated NCCN criteria to previously unqualified patients reveals missed opportunities for personalized cancer management |
|
|
|
|
|
|
|
|
|
| eP055: The Clinical Genome Resource (ClinGen) Somatic Cancer Clinical Domain Working Group |
|
|
|
|
|
|
|
|
|
| eP057: Precision oncology: Improvements in follow up and confirmation of potential germline variants identified from tumor next generation sequencing |
|
|
|
|
|
|
|
|
|
| eP066: Pitt-Hopkins syndrome, A high functioning family with milder phenotypes |
|
|
|
|
|
|
|
|
|
| eP087: Identification of an apparently de novo PKD1 variant in a patient with polycystic kidneys, renal angiomyolipoma, and lymphangioleiomyomatosis |
|
|
|
|
|
|
|
|
|
| eP092: Germline mosaicism in severe BICD2-associated lower extremity-predominant spinal muscular atrophy type 2 with arthrogryposis multiplex congenita |
|
|
|
|
|
|
|
|
|
| eP109: Clinical efficacy of next-generation sequencing panels for hearing loss diagnostics |
|
|
|
|
|
|
|
|
|
| eP120: Predicted frameshift variant in TSC2 associated with mild TSC phenotype and non-penetrance |
|
|
|
|
|
|
|
|
|
| eP122: The clinical significance of poisoned splicing variants in early-onset neurodevelopmental disorders |
|
|
|
|
|
|
|
|
|
| eP124: Uncovering rare obesity genetic testing program: Overview and health care provider utilization |
|
|
|
|
|
|
|
|
|
| eP127: Relationships between food-related behaviors, hyperphagia, obesity, and medication use in Smith-Magenis syndrome |
|
|
|
|
|
|
|
|
|
| eP136: An exploration of the impact of Hormonal Replacement Therapy (HRT) upon vocabulary skills in males with 49,XXXXY |
|
|
|
|
|
|
|
|
|
| eP151: Outcomes in growth hormone-treated Noonan syndrome children: Impact of PTPN11 variant status |
|
|
|
|
|
|
|
|
|
| eP154: Predictive genomic medicine for thoracic aortic aneurysm and dissection |
|
|
|
|
|
|
|
|
|
| eP157: Efficacy and safety of cipaglucosidase alfa/miglustat versus alglucosidase alfa/placebo in late-onset Pompe disease: PROPEL study |
|
|
|
|
|
|
|
|
|
| eP158: The utility of transcriptomics to increase diagnostic yield in cases of rare genetic disease |
|
|
|
|
|
|
|
|
|
| eP161: Homozygous deletion of the terminal exon of DSG3 associated with acantholytic blistering of the oral and laryngeal mucosa |
|
|
|
|
|
|
|
|
|
| eP165: Improvement in left ventricular ejection fraction in patients treated with triheptanoin for Long-chain Fatty Acid Oxidation Disorders (LC-FAOD) |
|
|
|
|
|
|
|
|
|
| eP173: Re-examination of the 2017 diagnostic criteria for hypermobile Ehlers-Danlos syndrome in patients evaluated at the University of Miami |
|
|
|
|
|
|
|
|
|
| eP175: Recurrent SMAD4 gain-of-function pathogenic variants cause brain and spine abnormalities in 40 patients followed in the MGH Myhre Syndrome Clinic |
|
|
|
|
|
|
|
|
|
| eP176: Metabolomics reveals measurable perturbations in de novo ceramide biosynthesis in DEGS1 associated-hypomyelinating leukodystrophy - Towards a clinically significant biomarker profile |
|
|
|
|
|
|
|
|
|
| eP178: The infrequent and complicated case of differentiating between two similar yet rare syndromes in a young patient |
|
|
|
|
|
|
|
|
|
| eP181: Expanding the phenotype of LMNB1 duplication: Three generation family with microcephalic infant, asymptomatic individual, and eldest member without leukodystrophy |
|
|
|
|
|
|
|
|
|
| eP182: KBG syndrome: Prospective videoconferencing and use of AI-driven facial phenotyping |
|
|
|
|
|
|
|
|
|
| eP185: A novel, milder case of CHEDDA syndrome caused by a de novo variant outside of the canonical HX-motif of ATN1 |
|
|
|
|
|
|
|
|
|
| eP207: NIH Down syndrome resources: DS-Connect Registry and INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project |
|
|
|
|
|
|
|
|
|
| eP208: GSD IX natural history and novel liver disease severity score: Multicenter international collaboration uncovers longitudinal trends in liver disease severity |
|
|
|
|
|
|
|
|
|
| eP223: Dominant-acting MAP3K20 variants cause split-foot malformation and sensorineural hearing loss |
|
|
|
|
|
|
|
|
|
| eP228: Multiple copy number losses in female with autism, developmental delay and focal epilepsy |
|
|
|
|
|
|
|
|
|
| eP240: Pursuit of a diagnosis for severe skeletal dysplasia: Case of a compound MYH3 VUS heterozygote after negative exome sequencing |
|
|
|
|
|
|
|
|
|
| eP246: Novel EFTUD2 variant adds to understanding of phenotypic spectrum of mandibulofacial dysostosis with microcephaly |
|
|
|
|
|
|
|
|
|
| eP248: Impact of DNA methylation signature exploration for variants of uncertain significance within epigenetic syndromes |
|
|
|
|
|
|
|
|
|
| eP254: Novel variant in AHDC1 leading to Xia-Gibbs syndrome: Expansion of the phenotype |
|
|
|
|
|
|
|
|
|
| eP265: Higher rates of non-skeletal complications in achondroplasia compared to the general population: A UK matched cohort study using CPRD-GOLD database |
|
|
|
|
|
|
|
|
|
| eP269: Reanalysis of commercial exome trio data reveals a de novo loss of function variant in KAT6A |
|
|
|
|
|
|
|
|
|
| eP272: Familial pathogenic variant causing osteogenesis imperfecta identified in the Puerto Rican population |
|
|
|
|
|
|
✓ |
|
Puerto Rican population |
| eP278: New cases of FDXR-associate disorder in twin brothers and failed mitochondrial cocktail trial treatment |
|
|
|
|
|
|
|
|
|
| eP282: Alpelisib for the treatment of PIK3CA-related head and neck lymphatic malformations and overgrowth |
|
|
|
|
|
|
|
|
|
| eP287: Return of individual genetic results in the largest recontactable cohort of individuals with autism |
|
|
|
|
|
|
|
|
|
| eP289: Non-cirrhotic portal hypertension: Expanding the phenotype of CBL syndrome-related vasculopathy |
|
|
|
|
|
|
|
|
|
| eP296: Familial MECP2 variants: a report of 4 affected families highlighting the variable phenotypic spectrum and implications for genetic counseling |
|
|
|
|
|
|
|
|
|
| eP302: Examining a hereditary cancer STAT panel and the importance of automatic reflex testing |
|
|
|
|
|
|
|
|
|
| eP318: Concurrent somatic 9p21 deletion and germline EP300 variant in a patient with T-ALL, immunodeficiency and malformations: Phenotypic expansion or comorbidities? |
|
|
|
|
|
|
|
|
|
| eP343: Long-read genome sequencing informs the molecular etiology of imprinting disorders |
|
|
|
|
|
|
|
|
|
| eP347: Rare variants and complex genomic structure of CYP2D6 necessitate careful assessment and interpretation of haplotype and copy number data |
|
|
|
|
|
|
|
|
|
| eP349: Describing the Impact of Genomic Variation on Function (IGVF) Consortium submitted on behalf of the IGVF Consortium members |
|
|
|
|
|
|
|
|
|
| eP369: Increased automation reduces turnaround time for submissions to ClinVar |
|
|
|
|
|
|
|
|
|
| eP373: Analytical validation of a computational method for pharmacogenetic genotyping from clinical exome sequencing |
|
|
|
|
|
|
|
|
|
| eP376: NGS detection of NUDT15 6-bp insertion and UGT1A1 (TA) repeat polymorphism on a preventative genomics assay |
|
|
|
|
|
|
|
|
|
| eP378: A 9-year, single-institution retrospective study of chromosomal microarray analysis data obtained from products of conception |
|
|
|
|
|
|
|
|
|
| eP383: Mayo Clinic GeneGuide: A population-scale genetic interpretation software for reporting pathogenic and likely pathogenic variants impacting the CDC Tier1 genes |
|
|
|
|
|
|
|
|
|
| eP392: A comprehensive genomic test reporting structure for communicating cancer and incidental findings |
|
|
|
|
|
|
|
|
|
| eP400: Utility of genome sequencing in CNV identification in an immune disorders cohort |
|
|
|
|
|
|
|
|
|
| eP406: Germline 16p13.1 microdeletion identified during routine hematologic testing |
|
|
|
|
|
|
|
|
|
| eP409: Clinical utility of a sponsored, no-charge skeletal dysplasia gene panel testing program: Results from >2600 tests |
|
|
|
|
|
|
|
|
|
| eP412: An evidence-based framework to evaluate Melanocortin-4 Receptor (MC4R) pathway relevance for obesity-associated genes |
|
|
|
|
|
|
|
|
|
| eP419: Genotype-phenotype correlation of distal 18q deletions less than 5 Mb |
|
|
|
|
|
|
|
|
|
| eP421: Development of an in-house whole transcriptome test for evaluation of splicing VUS variants: Experience and challenges in variant interpretation |
|
|
|
|
|
|
|
|
|
| eP429: Factors associated with the time to complete clinical exome sequencing in a pediatric patient population |
|
|
|
|
|
|
|
|
|
| eP432: Beyond newborn screening: Family planning implications and considerations for parents of a child with severe combined immunodeficiency |
|
|
|
|
|
|
|
|
|
| eP433: Nephrologists’ views on return of genetic results to research participants |
|
|
|
|
|
|
|
|
|
| eP437: Recruitment of Veterans Affairs patients improves the diversity of precision medicine research participation |
|
|
|
|
|
|
|
|
|
| eP448: Multiple pregnancies with fetal akinesia deformation sequence caused by variants in MUSK |
|
|
|
|
|
|
|
|
|
| eP449: Expansion of the prenatal phenotype of PIEZO1 variants |
|
|
|
|
|
|
|
|
|
| eP458: Prenatal genetic diagnosis of fetal ultrasound anomalies by exome sequencing: A Chinese multi-center prospective cohort |
|
|
|
|
|
|
✓ |
|
Chinese |
| eP465: Role of next-generation sequencing in the evaluation of families with non-immune fetal hydrops |
|
|
|
|
|
|
|
|
|
| eP473: Patient attitudes and preferences about expanded noninvasive prenatal screening |
|
|
|
|
|
|
|
|
|
| eP482: The Biorepository and Integrative Genomics (BIG) Initiative: Addressing genomic health care disparities in underserved communities |
|
|
|
|
|
|
|
|
|
| eP484: Scaling a high throughput next generation sequencing laboratory for community surveillance of SARS-CoV-2 viral variants during the public health crisis |
|
|
|
|
|
|
|
|
|
| eP502: How will returning variants of uncertain significance impact healthcare use? A cross-sectional survey |
|
|
|
|
|
|
|
|
|
| eP506: Implementing diverse community engagement studios: The Family History and Cancer Risk Study (FOREST) at Vanderbilt and Meharry Medical College |
|
|
|
|
|
|
|
|
|
| eP510: High patient satisfaction with specialty pediatric services using telemedicine during the COVID-19 pandemic |
|
|
|
|
|
|
|
|
|
| eP516: Cost-effectiveness frameworks for comparing genome and exome sequencing versus conventional diagnostic pathways |
|
|
|
|
|
|
|
|
|
| eP517: Differences in genetic testing uptake in a large metropolitan pediatric outpatient genetics clinic over time |
|
|
|
|
|
|
|
|
|
| OP001: Quality of care metrics in patients with inborn errors of metabolism |
|
|
|
|
|
|
|
|
|
| OP002: Secondary data analysis: Opportunities to advance genetic disease understanding and newborn screening research |
|
|
|
|
|
|
|
|
|
| OP014: Fibroblast testing can inform medical management in individuals with mosaic variants detected on hereditary cancer panels |
|
|
|
|
|
|
|
|
|
| OP020: Demonstrating the value of genome sequencing in a pediatric neurology cohort: A successful partnership between a patient organization and industry |
|
|
|
|
|
|
|
|
|
| OP035: Rapid Whole Genome Sequencing (rWGS) in the cardiac NICU |
|
|
|
|
|
|
|
|
|
| OP039: Best practices for the interpretation and reporting of clinical genome sequencing |
|
|
|
|
|
|
|
|
|
| OP040: Clinical validation of tagmentation-based genome sequencing for germline disorders |
|
|
|
|
|
|
|
|
|
| OP052: Genetic etiology of prenatally detected isolated moderate to severe ventriculomegaly |
|
|
|
|
|
|
|
|
|
| eP065: Rare germline variants identified using genome sequencing in patients with hereditary cancer |
|
|
|
|
|
|
|
|
|
| eP310: Methods to disclose inherited cancer genetic test results in a population-based research study of Black women with invasive breast cancer |
|
|
|
|
|
|
|
|
|
| eP475: Long-term follow-up on fetuses diagnosed in second trimester with isolated single umbilical artery and normal chromosomal microarray |
|
|
|
|
|
|
|
|
|
| Masthead |
|
|
|
|
|
|
|
|
|
| Implementation of preemptive DNA sequence–based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study |
|
|
|
|
|
|
|
|
|
| eP001: Newborn screening experience for very long chain Acyl-CoA Dehydrogenase (VLCAD) deficiency in Kuwait |
|
|
|
|
|
|
|
|
|
| eP007: Delayed onset hyperammonemic encephalopathy in an adult with GLUD1 deficiency |
|
|
|
|
|
|
|
|
|
| eP011: Diagnosis of DNAJC12-deficient hyperphenylalaninemia offers targeted therapeutic options to counteract neurotransmitter deficiency |
|
|
|
|
|
|
|
|
|
| eP017: GNE gene variants associated with thrombocytopenia with or without GNE myopathy |
|
|
|
|
|
|
|
|
|
| eP032: Measurement of Nicotinamide Adenine Dinucleotide (NAD+) from dried blood spot cards |
|
|
|
|
|
|
|
|
|
| eP033: COASY-associated pontocerebellar hypoplasia – A possible additional secondary target detectable by expanded newborn screening? |
|
|
|
|
|
|
|
|
|
| eP043: Membrane Metalloendopeptidase (MME) positively regulates Phosphoinositide 3-Kinase (PI3K) signaling in triple negative breast cancer |
|
|
|
|
|
|
|
|
|
| eP047: Germline cancer predisposition variants in a cohort of early-onset Merkel cell carcinoma patients |
|
|
|
|
|
|
|
|
|
| eP049: Discordant fluorescence in situ hybridization and RNASeq results in the identification of fusion partners in recurring translocations in hematological malignancies |
|
|
|
|
|
|
|
|
|
| eP053: Detection of rare and novel fusions in pediatric B-Lymphoblastic Leukemia (B-ALL) by capture-based transcriptome sequencing (RNA-Seq) |
|
|
|
|
|
|
|
|
|
| eP056: Myelodysplastic syndrome/myeloproliferative neoplasm with highly complex intrachromosomal rearrangements resulting from multiple 5q15q32 deletions, 5’PDGFRβ deletion, pericentric inversion and |
|
|
|
|
|
|
|
|
|
| eP060: Characterizing the complex chromosomal rearrangements in a Philadelphia negative BCR/ABL1 positive case |
|
|
|
|
|
|
|
|
|
| eP062: Clinically significant goiters as the initial presentation of PTEN hamartoma tumor syndrome |
|
|
|
|
|
|
|
|
|
| eP063: Genetic variants associated with childhood cancers: Curation initiatives of the ClinGen Somatic Cancer Pediatric Taskforce |
|
|
|
|
|
|
|
|
|
| eP064: Consumer-initiated genetic testing identifies individuals predisposed to multiple hereditary cancer syndromes |
|
|
|
|
|
|
|
|
|
| eP068: Homozygous SMN1 single nucleotide variant in a patient with SMA type 0 |
|
|
|
|
|
|
|
|
|
| eP075: The evolution of a diagnostic odyssey |
|
|
|
|
|
|
|
|
|
| eP080: A rare case of mosaic trisomy 15 with chylothorax |
|
|
|
|
|
|
|
|
|
| eP093: De novo interstitial deletion of chromosome 7p22.1p21.2: A case report |
|
|
|
|
|
|
|
|
|
| eP106: BRSK2-related neurodevelopmental disorder: Novel pathogenic variant and review of literature |
|
|
|
|
|
|
|
|
|
| eP133: Genome sequencing and chromosomal microarray as a tool for evaluating phenotypic variability in individuals with X and Y chromosome variations |
|
|
|
|
|
|
|
|
|
| eP134: Functional characterization of Variants of Uncertain Significance (VUSs) identified in patients with early-life epilepsy in Hong Kong |
|
|
|
|
|
|
|
|
|
| eP138: An informatics star allele calling workflow for direct typing of CYP2D6 from fully phased variants using PacBio HiFi reads |
|
|
|
|
|
|
|
|
|
| eP143: Newborn screening for X-linked adrenoleukodystrophy: Identification of isodisomy of X in an affected female infant |
|
|
|
|
|
|
|
|
|
| eP145: Severe Pierre Robin sequence and hydrocephalus in infant with TUBB3 variant |
|
|
|
|
|
|
|
|
|
| eP146: Application of exome sequencing in patients of congenital anomalies with or without intellectual disability |
|
|
|
|
|
|
|
|
|
| eP162: Mosaic variant in ENG in infant with pulmonary arteriovenous malformations: Case report and review of hereditary hemorrhagic telangiectasia |
|
|
|
|
|
|
|
|
|
| eP167: The impact of glycogen storage disease type III on children and adults: Results from an online survey |
|
|
|
|
|
|
|
|
|
| eP169: A case report of Ververi-Brady syndrome: Expanding the genotype and phenotype |
|
|
|
|
|
|
|
|
|
| eP171: Family of three with truncating pathogenic variant in NFIA leading to central nervous system and urinary tract defects |
|
|
|
|
|
|
|
|
|
| eP179: Expanding the phenotype of CLCN6-associated early-onset neurodegeneration |
|
|
|
|
|
|
|
|
|
| eP186: Novel SNRPE-related spliceosomopathy characterized by microcephaly and congenital atrichia |
|
|
|
|
|
|
|
|
|
| eP191: Isodicentric(Y)(p11.2) mosaicism in newborn with 46,XX cells |
|
|
|
|
|
|
|
|
|
| eP205: Pharmacogenetic profiling via genome sequencing in children with medical complexity |
|
|
|
|
|
|
|
|
|
| eP206: Novel variant in ARSA associated with late infantile metachromatic leukodystrophy and heterozygote rate in individuals of Ashkenazi Jewish ancestry |
|
|
|
|
|
|
✓ |
|
Ashkenazi Jewish ancestry |
| eP213: Phase 2 multiple ascending-dose study of SRP-5051 PPMO in patients with DMD amenable to exon 51 skipping: Part A results |
|
|
|
|
|
|
|
|
|
| eP214: Prevalence of cardiac manifestations in patients with hypermobile Ehlers-Danlos syndrome at the University of Miami |
|
|
|
|
|
|
|
|
|
| eP222: Gene variant and neuromuscular findings from a long-chain fatty acid oxidation disorder gene panel program |
|
|
|
|
|
|
|
|
|
| eP225: Novel compound variants in IGHMBP2 associated with CMT |
|
|
|
|
|
|
|
|
|
| eP227: Placental accelerated aging in antenatal depression |
|
|
|
|
|
|
|
|
|
| eP245: INCEPTUS multinational, prospective, natural history, run-in study of males with X-linked myotubular myopathy |
|
|
|
|
|
|
|
|
|
| eP256: Intrafamilial variability in chromosome 2q13 microdeletion: Case report and review of the literature |
|
|
|
|
|
|
|
|
|
| eP258: Pre-analytical considerations are important in the pharmacological assessment of enzyme therapeutics |
|
|
|
|
|
|
|
|
|
| eP268: DVL2 – A newly identified genetic cause of Robinow syndrome? |
|
|
|
|
|
|
|
|
|
| eP276: Development of an overdue outreach program to improve adherence to phenylketonuria management |
|
|
|
|
|
|
|
|
|
| eP279: More renal genetics specialists are needed: Experience from a tertiary medical center |
|
|
|
|
|
|
|
|
|
| eP285: Hidden threats: Identifying genetic risks for cardiomyopathy complications in healthy pregnant women |
|
|
|
|
|
|
|
|
|
| eP290: A mosaic Angelman syndrome case with language apraxia and symptoms overlapping Prader-Willi syndrome |
|
|
|
|
|
|
|
|
|
| eP312: Exon level array utility in follow up to identification of copy number variants on expanded carrier screening |
|
|
|
|
|
|
|
|
|
| eP317: Comparative benchmarking of optical genome mapping and chromosomal microarray reveals high technological concordance in CNV identification and structural variant refinement |
|
|
|
|
|
|
|
|
|
| eP320: AI-based method to estimate the probability of a variant being an artifact |
|
|
|
|
|
|
|
|
|
| eP323: Case-control study to identify key residues and domains within hereditary renal disease gene panel to aid in VUS reclassification |
|
|
|
|
|
|
|
|
|
| eP324: Biallelic variants in DLL1 as a novel cause of severe spondylocostal dysostosis |
|
|
|
|
|
|
|
|
|
| eP344: Making the grade: How carrier screening panels score against the American College of Medical Genetics and Genomics “Tier 3” recommendations |
|
|
|
|
|
|
|
|
|
| eP361: Democratizing carrier screening: A 34-gene panel of routine and challenging targets resolved using a single workflow |
|
|
|
|
|
|
|
|
|
| eP367: How a GUS can fly: Triaging genes of uncertain significance in a clinical laboratory setting |
|
|
|
|
|
|
|
|
|
| eP381: Diverse presentation of PARK2 gene variant patients: Array CGH study of nine cases with PARK2 disruption |
|
|
|
|
|
|
|
|
|
| eP382: Providing more answers for patients with supplemental RNA analysis |
|
|
|
|
|
|
|
|
|
| eP384: Clinical, epidemiological and genetic characteristics of children diagnosed with Multisystem Inflammatory Syndrome (MIS-C) in Kuwait |
|
|
|
|
|
|
|
|
|
| eP388: Optical genome mapping capability expanded to enable detection of absence of heterozygosity |
|
|
|
|
|
|
|
|
|
| eP390: Leveraging unique chromosomal microarray probes to resolve complex copy number variation at the highly homologous deafness-infertility syndrome locus at 15q15.3 |
|
|
|
|
|
|
|
|
|
| eP395: Calculating recurrence risk in an individual with an intrachromosomal structural rearrangement |
|
|
|
|
|
|
|
|
|
| eP404: Evidence supporting the pathogenicity of the NADSYN1 c.1717G>A (p.Ala573Thr) variant in individuals referred for clinical testing |
|
|
|
|
|
|
|
|
|
| eP416: Assessment of the clinical implication of additional cytogenetic abnormalities in acute lymphoblastic leukemia with t(4;11)(q21;q23) |
|
|
|
|
|
|
|
|
|
| eP420: Clinical utility of a 38-gene NGS panel in diagnosing patients with hemolytic anemia: A retrospective review of 435 cases |
|
|
|
|
|
|
|
|
|
| eP428: Gender and sex discordance in genetic testing: Mayo Clinic Genomics Laboratory experience |
|
|
|
|
|
|
|
|
|
| eP434: Celebrating and commemorating the 2022 bicentennial of Mendel’s birth, the exhumation of Mendel's body for archeologic, anthropologic, and genomic research |
|
|
|
|
|
|
|
|
|
| eP435: Issues in interpreting results in research genomic testing for common disorders: an example within an OCD cohort |
|
|
|
|
|
|
|
|
|
| eP438: Ethical issues related to gene therapy with onasemnogene abeparvovec for spinal muscular atrophy type 1 in a developing country |
|
|
|
|
|
|
|
|
|
| eP441: Evaluation of growth in perceived clinical genetics competency among primary care providers participating in genomic population health screening |
|
|
|
|
|
|
|
|
|
| eP444: Cases of isodicentric and isochromosome-related false negatives on SNP-based cell free DNA aneuploidy screening |
|
|
|
|
|
|
|
|
|
| eP453: Diagnosis of Hereditary Hemorrhagic Telangiectasia (HHT) in the postpartum period: A case report |
|
|
|
|
|
|
|
|
|
| eP455: Fetal ultrasound presentation and neonatal diagnosis of Freeman-Sheldon syndrome in son of previously undiagnosed adult male |
|
|
|
|
|
|
|
|
|
| eP466: The use of next generation prenatal screening in a low resource setting among Non-Hispanic Black and Hispanic patients |
|
|
|
|
|
|
✓ |
|
Non-Hispanic Black and Hispanic patients |
| eP478: Identifying the current status and future needs of clinical, educational, and laboratory genetics services in Pakistan: A web-based panel discussion |
|
|
|
|
|
|
|
|
|
| eP480: Project ECHO for pediatric genetics in Mississippi: Expanding access to the clinical genetics workup for autism and intellectual disability |
|
|
|
|
|
|
|
|
|
| eP492: The ScreenPlus model for collective funding of pilot newborn screening |
|
|
|
|
|
|
|
|
|
| eP494: Integration of genomics into primary care via the Alabama Genomic Health Initiative |
|
|
|
|
|
|
|
|
|
| eP495: Introduction to Odyssey: Real-world rare disease data collection program for patients with long-chain fatty acid oxidation disorders in the US |
|
|
|
|
|
|
|
|
|
| eP498: Detection of congenital cytomegalovirus infection on high-risk newborn population |
|
|
|
|
|
|
|
|
|
| eP508: Integration of personalized medicine into primary care clinics: A path to make large scale population genomics studies successful |
|
|
|
|
|
|
|
|
|
| eP511: Improved insurance coverage of exome sequencing in an outpatient medical genetics clinic increases in diagnoses and positively impacts clinical management |
|
|
|
|
|
|
|
|
|
| eP513: “Doctors shouldn’t have to cheat the system”: Clinicians’ real-world experiences of the utility of genomic sequencing |
|
|
|
|
|
|
|
|
|
| OP006: Is it time to move beyond acylcarnitine profiles? Lessons from the clinical application of a high-definition LC-MS/MS acylcarnitine method. |
|
|
|
|
|
|
|
|
|
| OP025: Integration of genome sequencing in the inpatient setting: A mixed methods study exploring collaboration models between genetics and bedside teams |
|
|
|
|
|
|
|
|
|
| OP026: Genetic counseling for personal health risk in individuals heterozygous for hypophosphatasia variants identified through expanded carrier screening |
|
|
|
|
|
|
|
|
|
| OP028: At the intersection of technology and genetics: A pilot study exploring virtual assistant use with non-invasive prenatal screening result disclosure |
|
|
|
|
|
|
|
|
|
| OP036: Application of RNA sequencing evidence improves equity in variant interpretation |
|
|
|
|
|
|
|
|
|
| OP037: Assessing the impact of expanded ACMG secondary findings recommendations on population genomic screening in the Geisinger MyCode Community Health Initiative |
|
|
|
|
|
|
|
|
|
| OP051: Genetic characteristics and prenatal phenotyping of RASopathy spectrum diagnosed by exome sequencing for nonimmune hydrops fetalis |
|
|
|
|
|
|
|
|
|
| OP055: Comparing error rates in disclosure of genome sequencing results between non-genetics providers and genetic counselors |
|
|
|
|
|
|
|
|
|
| OP060: Rare diseases, common barriers: Disparities in clinical genetics outcomes |
|
|
|
|
|
|
|
|
|
| eP002: Pilot study of insulin-like growth factor 1 on differing metabolic responders with Phelan-McDermid syndrome: Preliminary results |
|
|
|
|
|
|
|
|
|
| eP003: Novel use of IL-1 inhibition via canakinumab in two patients with lysinuric protein intolerance and immune dysregulation |
|
|
|
|
|
|
|
|
|
| eP004: Screening for metabolic abnormalities in a cohort of patients with hypermobility |
|
|
|
|
|
|
|
|
|
| eP006: Homocystinuria in an adolescent patient with Chr21q22.2q22.3 deletion |
|
|
|
|
|
|
|
|
|
| eP010: Conservative management with serial biochemical monitoring for newborn screen detected Maple Syrup Urine Disease (MSUD) patients without metabolic decompensation |
|
|
|
|
|
|
|
|
|
| eP019: Case presentation: Dual diagnosis of LCHAD deficiency and type 1 diabetes mellitus and complexities of management |
|
|
|
|
|
|
|
|
|
| eP021: Case report of a Mexican family with alpha mannosidosis and a novel probably pathogenic variant in the MAN2B1 gene |
|
|
|
|
|
|
|
|
|
| eP028: Neurological manifestations in PMM2 related congenital disorders of glycosylation (CDG): Insights into clinico-radiological characteristics and recommendations for follow-up |
|
|
|
|
|
|
|
|
|
| eP031: Clinical and biochemical characterization of carnitine palmitoyltransferase-2 deficiency and novel case exacerbated by heterozygosity with partial carnitine transporter deficiency |
|
|
|
|
|
|
|
|
|
| eP036: Not your typical newborn screen for X-ALD: Outcomes from Washington State |
|
|
|
|
|
|
|
|
|
| eP039: Does Lynch syndrome cause predisposition to breast cancer? Experience from a hereditary breast cancer clinic in Pakistan |
|
|
|
|
|
|
|
|
|
| eP082: Associated recessive retinitis pigmentosa caused by paternal uniparental disomy |
|
|
|
|
|
|
|
|
|
| eP085: Phenotype of two old order Amish patients with NOD2 increased risk alleles |
|
|
|
|
|
|
✓ |
|
old order Amish |
| eP086: Hypophosphatemia gene panel sponsored program: A high yield of molecular diagnoses from clinically confirmed XLH and suspected genetic hypophosphatemia |
|
|
|
|
|
|
|
|
|
| eP091: Improving cytogenetic testing utilization in a tertiary care NICU through quality improvement |
|
|
|
|
|
|
|
|
|
| eP095: A family-based study of hereditary spastic paraplegia type 46 in two siblings due to a novel GBA2 variant |
|
|
|
|
|
|
|
|
|
| eP097: The utility of CSF-derived cell free DNA in molecular diagnostics for the Megalencephaly-capillary Malformation (MCAP) syndrome: A case report |
|
|
|
|
|
|
|
|
|
| eP113: Prevalence and clinical consequences of genetic variants associated with familial hypercholesterolemia and LDL-C lowering in a diverse patient population |
|
|
|
|
|
|
|
|
|
| eP126: Frequency of MC4R pathway variants in a large US cohort of pediatric and adult patients with severe obesity |
|
|
|
|
|
|
|
|
|
| eP129: Prevention of atypical hemolytic uremic syndrome with eculizumab in cardiopulmonary bypass: The importance of genomics in congenital heart disease |
|
|
|
|
|
|
|
|
|
| eP130: Infantile hypertrophic cardiomyopathy due to HRAS related Costello syndrome responsive to trametinib: Outcomes after 2 years |
|
|
|
|
|
|
|
|
|
| eP132: Congenital diaphragmatic hernia as a feature of Coffin Siris syndrome type 2 |
|
|
|
|
|
|
|
|
|
| eP152: A case of atypical Crouzon syndrome with congenital diaphragmatic hernia |
|
|
|
|
|
|
|
|
|
| eP153: WASF2 variants contribute to heart failure phenotypes |
|
|
|
|
|
|
|
|
|
| eP166: Vestronidase alfa for the treatment of Mucopolysaccharidosis VII (MPS VII): Updated results from a novel, longitudinal, multicenter disease monitoring program |
|
|
|
|
|
|
|
|
|
| eP168: A de novo variant in AMOTL1 gene in an adult with craniofacial abnormalities and previously unreported congenital diaphragmatic hernia |
|
|
|
|
|
|
|
|
|
| eP180: Polygenic risk score as a possible tool for identifying familial monogenic causes of complex diseases |
|
|
|
|
|
|
|
|
|
| eP198: EIF3F compound heterozygous genotype-phenotype association |
|
|
|
|
|
|
|
|
|
| eP215: MED12-related Hardikar syndrome- Two additional cases and novel phenotypic features including cholangiocarcinoma |
|
|
|
|
|
|
|
|
|
| eP219: Genome Sequencing (GS) as a first test in the clinic |
|
|
|
|
|
|
|
|
|
| eP226: Dual diagnoses in neurogenetics- A case series of pediatric movement disorders and clinical management |
|
|
|
|
|
|
|
|
|
| eP235: Interim results of the Vigilan observational study: clinical characteristics of creatine transporter deficiency |
|
|
|
|
|
|
|
|
|
| eP238: Inner epicanthal and nasal pits as presenting feature of holoprosencephaly |
|
|
|
|
|
|
|
|
|
| eP239: Diagnostic performance of automated streamlined, daily updated, exome analysis in patients with delayed development |
|
|
|
|
|
|
|
|
|
| eP249: Practical implementation of inpatient rapid comprehensive sequencing for critically ill pediatric patients |
|
|
|
|
|
|
|
|
|
| eP257: A homozygous nonsense variant in DNAJC30 causes Leigh-like phenotypes |
|
|
|
|
|
|
|
|
|
| eP303: A tale of two tests: A PGT-M and expanded carrier screening clinical experience study |
|
|
|
|
|
|
|
|
|
| eP307: The impact of proband indication for genetic testing on the uptake of cascade testing among relatives |
|
|
|
|
|
|
|
|
|
| eP333: Tracking the emergence of SARS-CoV-2 variants of concern in vaccinated and unvaccinated patients |
|
|
|
|
|
|
|
|
|
| eP340: Clinical and genetic features of a large cohort of individuals with autoinflammatory disease |
|
|
|
|
|
|
|
|
|
| eP342: Clinical testing of SHOX gene for SHOX deficiency disorders |
|
|
|
|
|
|
|
|
|
| eP350: QuaC: Implementing quality control best practices for genome sequencing and exome sequencing data |
|
|
|
|
|
|
|
|
|
| eP351: Next-generation sequencing panels for cystic kidney disease with improvements for sequencing and alignment challenges |
|
|
|
|
|
|
|
|
|
| eP355: Repeat expansion disorders screening by genome sequencing: Strategy and stumbling blocks |
|
|
|
|
|
|
|
|
|
| eP362: Mosaic RAS family in-frame insertion variants in patients with hemangiomas and vascular malformations |
|
|
|
|
|
|
|
|
|
| eP363: A review of characteristic features identifying balanced chromosomal translocations with increased potential for 3:1 meiotic segregation |
|
|
|
|
|
|
|
|
|
| eP364: Lessons from pathogenicity classifications for 251 RYR1 variants associated with malignant hyperthermia susceptibility using variant curation expert panel revised criteria |
|
|
|
|
|
|
|
|
|
| eP370: SouthSeq: Genome sequencing for a diverse population of hospitalized infants |
|
|
|
|
|
|
|
|
|
| eP371: A diverse set of case presentation highlight the power of genome sequencing – What next? |
|
|
|
|
|
|
|
|
|
| eP374: Variant classification changes over time at a clinical molecular diagnostic laboratory |
|
|
|
|
|
|
|
|
|
| eP387: Genetic testing for spinocerebellar ataxias in pediatric patients |
|
|
|
|
|
|
|
|
|
| eP397: Inadvertent allogeneic hematopoietic stem cell transplant from a lung allograft |
|
|
|
|
|
|
|
|
|
| eP398: Searching beyond the exons in nuclear genes: Diagnostic deep intronic and mitochondrial variants in patients with monogenic diabetes |
|
|
|
|
|
|
|
|
|
| eP401: Comprehensive evaluation of genetic etiology underlying non-immune hydrops fetalis |
|
|
|
|
|
|
|
|
|
| eP407: Aberrant KCNQ1 splicing as an emerging mechanism underlying the pathogenesis of familial Beckwith-Wiedemann syndrome with reduced penetrance |
|
|
|
|
|
|
|
|
|
| eP411: Tackling the COVID-19 pandemic by utilizing next generation sequencing technologies |
|
|
|
|
|
|
|
|
|
| eP417: Exome sequencing unravels dual diagnoses and complex molecular etiologies in a family with prior negative diagnostic testing |
|
|
|
|
|
|
|
|
|
| eP425: Parental impact of genome sequencing during the neonatal period |
|
|
|
|
|
|
|
|
|
| eP427: Disseminating genetics policy information on social media |
|
|
|
|
|
|
|
|
|
| eP440: Developing medical genetics interest and literacy through student interest groups: The why, the how, and the challenges |
|
|
|
|
|
|
|
|
|
| eP446: High rates of ‘atypical’ panorama noninvasive prenatal screening results among consanguineous Arab American women |
|
|
|
|
|
|
✓ |
|
Arab American |
| eP447: Family history helps solve the case: Prenatal case report of Lowe syndrome |
|
|
|
|
|
|
|
|
|
| eP450: Effectiveness and utility of noninvasive prenatal screening (NIPS) for sex chromosome aneuploidies |
|
|
|
|
|
|
|
|
|
| eP454: Fetal exome sequencing for recurrent arthrogryposis identifies a potentially causative variant in the TOR1A gene: A case report |
|
|
|
|
|
|
|
|
|
| eP457: Fetal presentation of pyruvate dehydrogenase complex deficiency diagnosed by prenatal exome sequencing |
|
|
|
|
|
|
|
|
|
| eP468: Carrier frequency of genes associated with autosomal recessive conditions in diverse populations: Lessons learned from gnomAD and ClinVar |
|
|
|
|
|
|
|
|
|
| eP469: Improved Vanadis NIPT platform for detection of T13 T18 and T21 and sex chromosome abnormalities |
|
|
|
|
|
|
|
|
|
| eP474: Prenatal exome sequencing analysis in the clinical setting of fetuses with structural anomalies or increased nuchal translucency |
|
|
|
|
|
|
|
|
|
| eP485: Ancestry inference from targeted NGS tests to enable precision medicine and improve racial/ethnic representation in clinical trials |
|
|
|
|
|
|
✓ |
|
ancestry; racial/ethnic |
| eP491: COVID-19 and clinical genomics: A Detroit community hospital’s telehealth experience |
|
|
|
|
|
|
|
|
|
| eP497: Interpreting for genetics: Crossing the language barrier in communities |
|
|
|
|
|
|
|
|
|
| eP499: Performance measures for evaluating access to genetic services: Work of the National Coordinating Center for the seven Regional Genetics Networks |
|
|
|
|
|
|
|
|
|
| eP500: Genome-wide Sequencing Ontario (GSO): An implementation pilot to improve rare disease diagnostics |
|
|
|
|
|
|
|
|
|
| eP504: A novel visualization of state-by-state variability in newborn screening highlights underrepresentation of lysosomal storage disorders |
|
|
|
|
|
|
|
|
|
| eP518: Development and validation of the Vanderbilt PRS-KS, an instrument to quantify polygenic risk score knowledge |
|
|
|
|
|
|
|
|
|
| OP012: Perceptions of breast and ovarian cancer risk and genetic testing among Non-Hispanic Black women |
|
|
|
|
|
|
✓ |
|
Non-Hispanic Black |
| OP016: Mini-COMET: Safety and efficacy of ≥97 weeks’ avalglucosidase alfa in infantile-onset Pompe disease participants previously treated with alglucosidase alfa |
|
|
|
|
|
|
|
|
|
| OP017: Triheptanoin for the treatment of Long-Chain Fatty Acid Disorders (LC-FAOD): Final results of an open-label, long-term extension study |
|
|
|
|
|
|
|
|
|
| OP030: Parenting stress raising children with sex chromosome aneuploidies: First year of life results from the eXtraordinarY Babies study |
|
|
|
|
|
|
|
|
|
| OP044: A survey of program directors for combined pediatrics-medical genetics and genomics residency programs: Perspectives when evaluating applicants |
|
|
|
|
|
|
|
|
|
| OP049: Automated isolation and genetic characterization of single circulating fetal trophoblasts in pregnant women |
|
|
|
|
|
|
|
|
|
| OP015: Multi-omic analysis of circulating tumour DNA for the early detection of cancer in patients with Li-Fraumeni syndrome |
|
|
|
|
|
|
|
|
|
| OP032: Communication practices of parents and unaffected sibling needs in families impacted by a diagnosis of Angelman syndrome |
|
|
|
|
|
|
|
|
|
| OP041: Implementation of 2019 ACMG technical standards for the interpretation and reporting of constitutional CNVs: Experiences from an academic reference laboratory |
|
|
|
|
|
|
|
|
|
| eP005: Complex glycerol kinase deficiency and X-linked intellectual disability |
|
|
|
|
|
|
|
|
|
| eP008: Cystathionine beta synthase deficiency patients are being missed by newborn screening |
|
|
|
|
|
|
|
|
|
| eP012: Biochemical characterization of single minded-1 missense variants associated with severe obesity |
|
|
|
|
|
|
|
|
|
| eP013: Novel biomarkers of succinic semialdehyde dehydrogenase deficiency highlight opportunities for screening and detection of GABA catabolism pathway abnormalities |
|
|
|
|
|
|
|
|
|
| eP014: Establishment of a clinically validated in vitro functional assay to score pathogenicity of novel GAA variants in Pompe patients |
|
|
|
|
|
|
|
|
|
| eP018: Late-onset congenital erythropoietic porphyria associated with myeloid malignancy |
|
|
|
|
|
|
|
|
|
| eP020: Expanding the clinical spectrum of asparagine synthetase deficiency |
|
|
|
|
|
|
|
|
|
| eP022: Action myoclonus-renal failure syndrome: An atypical storage disorder with a treatment dilemma |
|
|
|
|
|
|
|
|
|
| eP026: Newborn screening for Pompe disease: The Indiana experience |
|
|
|
|
|
|
|
|
|
| eP027: Screening for co-incident TANGO2 related metabolic encephalopathy and arrhythmia syndrome in 22q11 deletion syndrome |
|
|
|
|
|
|
|
|
|
| eP029: Response of an infant with presumed type II multiple Acyl-CoA dehydrogenase deficiency to ketone supplementation |
|
|
|
|
|
|
|
|
|
| eP030: Effect of peanut butter consumption on C26 concentrations in breastmilk -- Implications for X-ALD newborn screening |
|
|
|
|
|
|
|
|
|
| eP035: Genotype-phenotype correlation of glycogen storage disease type IV |
|
|
|
|
|
|
|
|
|
| eP037: Biochem for the Win! The added value of biochemical genetic testing for diagnosis and variant interpretation in the genomic era |
|
|
|
|
|
|
|
|
|
| eP040: Breast cancer patients categorized as high-risk of recurrence and/or basal-type molecular subtype by Agendia should universally undergo germline genetic testing |
|
|
|
|
|
|
|
|
|
| eP042: Highly sensitive blocker displacement amplification-based qPCR approach in detecting low level JAK2 variant |
|
|
|
|
|
|
|
|
|
| eP045: Papillary renal cell carcinoma, glioma and colon polyps in a patient with novel POT1 variant |
|
|
|
|
|
|
|
|
|
| eP048: Identifying cancer predisposition in a series of 1,521 pediatric oncology patients by tumor-only panel-based testing |
|
|
|
|
|
|
|
|
|
| eP050: Cytogenomic profiling and clinical correlation of 21q22 amplification in acute myeloid leukemia reveal distinct cytogenomic features and poor outcomes |
|
|
|
|
|
|
|
|
|
| eP052: Coding defects in chromosomal segregation and protein targeting are central to TGCT predisposition |
|
|
|
|
|
|
|
|
|
| eP054: Real-world clinical characteristics and management of breast cancer in patients with germline pathogenic variants in ATM, CHEK2 and PALB2 |
|
|
|
|
|
|
|
|
|
| eP058: Determining indications for genetic testing among breast cancer patients with inherited cancer pathogenic/likely pathogenic variants |
|
|
|
|
|
|
|
|
|
| eP059: Breast cancer characteristics among women with hereditary breast cancer |
|
|
|
|
|
|
|
|
|
| eP061: Genetic risk for breast and ovarian cancer in a diverse and unselected population |
|
|
|
|
|
|
|
|
|
| eP067: Diagnostic yield of genome sequencing versus targeted gene panel testing in diverse pediatric patients in the NYCKidSeq study |
|
|
|
|
|
|
|
|
|
| eP069: Possible founder variant and spectrum of phenotypic manifestation of Fukuyama muscular dystrophy reported in four unrelated Pakistani families |
|
|
|
|
|
|
|
|
|
| eP071: 45,X/46,XY mosaicism: Retrospective study of 100 patients |
|
|
|
|
|
|
|
|
|
| eP072: Disparities of racial and ethnic minorities in population genetic screening: Evidence and promising strategies |
|
|
|
|
|
|
|
|
|
| eP073: Interstitial deletion of 3q21 in a child with multiple congenital anomalies; Expanding the phenotype |
|
|
|
|
|
|
|
|
|
| eP074: Atypical presentation of a patient with Sotos syndrome with later onset overgrowth, mandibular hypoplasia, and cleft palate |
|
|
|
|
|
|
|
|
|
| eP076: Pancreatic lipase deficiency cohort in the plain population |
|
|
|
|
|
|
|
|
|
| eP077: Atypical polycystic kidney disease in individuals heterozygous for rare ALG8 protein-truncating variants |
|
|
|
|
|
|
|
|
|
| eP078: Phenotypes and genotypes in a cohort of children with single ventricle congenital heart disease |
|
|
|
|
|
|
|
|
|
| eP079: Cerebellar atrophy, developmental delay and a VUS in the THG1L gene: A case report |
|
|
|
|
|
|
|
|
|
| eP081: Dandy Walker malformation in three unrelated families with biallelic variants in CAPN15 expands the phenotypic spectrum of oculogastrointestinal neurodevelopmental disorder |
|
|
|
|
|
|
|
|
|
| eP088: Diagnosing a patient with progressive myoclonic epilepsy-12 with variants of uncertain significance on exome sequencing |
|
|
|
|
|
|
|
|
|
| eP089: 47, XXY: Mathematic capabilities and the impact of Hormonal Replacement Treatment (HRT) |
|
|
|
|
|
|
|
|
|
| eP090: Precision medicine modelling for undiagnosed and rare disease |
|
|
|
|
|
|
|
|
|
| eP094: Diagnostic yield of chromosomal microarray in congenital heart disease: A single center retrospective study |
|
|
|
|
|
|
|
|
|
| eP096: Novel pathogenic variants causing TBCK syndrome in three patients from Indian origin |
|
|
|
|
|
|
✓ |
|
Indian origin |
| eP098: Exome sequencing of >500 individuals with brain malformation phenotypes reveals marked genetic heterogeneity |
|
|
|
|
|
|
|
|
|
| eP099: Wiedemann-Rautenstrauch syndrome- New pathways for an old disease |
|
|
|
|
|
|
|
|
|
| eP101: The diagnostic odyssey towards detection of mosaic distal 5p tetrasomy through buccal swab DNA analysis |
|
|
|
|
|
|
|
|
|
| eP103: Speech development gene pathways: Would genome sequencing in nonverbal individuals provide a link? |
|
|
|
|
|
|
|
|
|
| eP104: Two patients with autism secondary to ZBTB18 loss-of-function pathogenic variants |
|
|
|
|
|
|
|
|
|
| eP107: Accurate genotyping of UGT1A1 dinucleotide repeat polymorphism from targeted NGS data for the assessment of irinotecan chemotherapy adverse events |
|
|
|
|
|
|
|
|
|
| eP108: PPP1CB-related Noonan syndrome with loose anagen hair presenting with focal cortical dysplasia and epilepsy |
|
|
|
|
|
|
|
|
|
| eP111: Microduplication 5q11.2q21.1 presenting with congenital scoliosis |
|
|
|
|
|
|
|
|
|
| eP112: Septo-optic dysplasia associated with unbalanced chromosome translocation resulting in trisomy 11q13 and monosomy 12q24.3 |
|
|
|
|
|
|
|
|
|
| eP114: De novo prenatal diagnosis of X-linked Acromegaly Gigantism (X-LAG) |
|
|
|
|
|
|
|
|
|
| eP115: Two novel NPR2 variants in a patient with acromesomelic dysplasia - Maroteaux type |
|
|
|
|
|
|
|
|
|
| eP116: Yield of exome sequencing in patients with abnormal head size |
|
|
|
|
|
|
|
|
|
| eP117: Natural history study of an international TANGO2 deficiency cohort |
|
|
|
|
|
|
|
|
|
| eP118: Connective tissue disorders not otherwise specified: Defining the problem |
|
|
|
|
|
|
|
|
|
| eP119: The landscape of peripheral neuropathy genetics: When common causes are not actually the cause |
|
|
|
|
|
|
|
|
|
| eP121: Integrating de novo and inherited variants in over 42,607 autism cases identifies variants in new moderate risk genes |
|
|
|
|
|
|
|
|
|
| eP123: Design of a phase 2, double-blind, placebo-controlled trial of setmelanotide in patients with genetic variants in the melanocortin-4 receptor pathway |
|
|
|
|
|
|
|
|
|
| eP125: Variants in obesity-related genes in a population with early-onset obesity |
|
|
|
|
|
|
|
|
|
| eP128: A novel CSNK1E variant in a patient with autism spectrum disorder |
|
|
|
|
|
|
|
|
|
| eP131: High prevalence of bony abnormalities in patients with Rubinstein-Taybi syndrome: A case series |
|
|
|
|
|
|
|
|
|
| eP137: Defining the disease entity for inherited retinal disorders – Lump or split? |
|
|
|
|
|
|
|
|
|
| eP139: Spatial transcriptomic approaches for characterizing childhood intellectual disability |
|
|
|
|
|
|
|
|
|
| eP141: Expansion of long-read genome sequencing for the molecular diagnosis of neurodevelopmental disorders and multiple congenital anomalies |
|
|
|
|
|
|
|
|
|
| eP142: Treatment resistant malignant catatonia in a patient with VAMP2-related disorder |
|
|
|
|
|
|
|
|
|
| eP144: Long-read genome sequencing secondary processing pipelines provide variant call accuracy that exceeds current clinical standards for short-read genome sequencing |
|
|
|
|
|
|
|
|
|
| eP148: Long-term safety and efficacy of pegunigalsidase alfa: A multicenter extension study in adult patients with Fabry disease |
|
|
|
|
|
|
|
|
|
| eP149: Safety and efficacy of pegunigalsidase alfa, every 4 weeks, in Fabry disease: Results from the phase 3, open-label, BRIGHT study |
|
|
|
|
|
|
|
|
|
| eP150: Mosaic 2q37 deletion detected in a neonate with IUGR and brain malformations |
|
|
|
|
|
|
|
|
|
| eP155: Genetic investigation of idiopathic short stature in the endocrinology practice: The Mayo Clinic experience |
|
|
|
|
|
|
|
|
|
| eP156: Pilot study of functional near-infrared spectroscopy of cortical brain function during an auditory and visual N-back task in Klinefelter syndrome |
|
|
|
|
|
|
|
|
|
| eP159: A TOPBP1 variant associated With BAFopathy methylation pattern |
|
|
|
|
|
|
|
|
|
| eP160: Bilateral oophorectomy and the risk of breast cancer in women with a pathogenic variant in BRCA1: A reappraisal |
|
|
|
|
|
|
|
|
|
| eP163: Germline mosaicism in two sisters with Malan syndrome |
|
|
|
|
|
|
|
|
|
| eP164: A case report of neurological manifestations and failure to thrive in neurobehavioural disease caused by a variant in RFX7 |
|
|
|
|
|
|
|
|
|
| eP170: When cfDNA screening deceives: A rare case of mosaicism for 46,XX/47,XXY with uniparental isodisomy and genital atypia |
|
|
|
|
|
|
|
|
|
| eP172: A new and milder case of primary autosomal recessive microcephaly type 16 |
|
|
|
|
|
|
|
|
|
| eP174: A novel variant of CXCR4 gene in a case of WHIM syndrome |
|
|
|
|
|
|
|
|
|
| eP183: Functional assessment of a novel POU4F3 missense variant |
|
|
|
|
|
|
|
|
|
| eP184: Novel KCNA1 pathogenic variant associated syndrome of episodic dystonia and electrophysiologic myokymia - A case report |
|
|
|
|
|
|
|
|
|
| eP188: Novel HECW2 variant presenting with tachypnea and multisystemic congenital malformations |
|
|
|
|
|
|
|
|
|
| eP189: Insights into the phenotype of KDM1A-related neurodevelopmental disorder: A new chromatinopathy |
|
|
|
|
|
|
|
|
|
| eP190: A third patient with RAP1B-related syndromic thrombocytopenia and novel clinical findings |
|
|
|
|
|
|
|
|
|
| eP192: Differences of Sex Development (DSD) in Central Africa: Genetics, psychosocial adaptation and perceptions |
|
|
|
|
|
|
|
|
|
| eP193: Co-occurring TCF12 and mosaic NALCN likely pathogenic variants: Case report of novel skeletal findings without craniosynostosis, neurologic dysfunction, and apnea |
|
|
|
|
|
|
|
|
|
| eP194: Three generations of females with a heterozygous likely pathogenic variant in SLC6A8 causative of X-linked creatine transporter defect |
|
|
|
|
|
|
|
|
|
| eP195: Safety and efficacy of Copper Histidinate (CUTX-101) treatment for Menkes disease caused by severe loss-of-function variants in ATP7A |
|
|
|
|
|
|
|
|
|
| eP196: Phenotypic and genotypic heterogeneity related to gene defects in TBL1XR1 |
|
|
|
|
|
|
|
|
|
| eP197: Further delineation of KIF21B-related neurodevelopmental disorders |
|
|
|
|
|
|
|
|
|
| eP200: Noonan syndrome associated with focal occipital alopecia in a patient with RAF1 variant: A case report and literature review |
|
|
|
|
|
|
|
|
|
| eP201: A phase 2 clinical trial evaluating the safety and efficacy of delandistrogene moxeparvovec for treating patients with Duchenne muscular dystrophy |
|
|
|
|
|
|
|
|
|
| eP202: A new pathologic KMT2B variant associated with childhood onset dystonia presenting as variable phenotypes among family members |
|
|
|
|
|
|
|
|
|
| eP203: Genotype/phenotype correlations in Joubert syndrome |
|
|
|
|
|
|
|
|
|
| eP204: Expert opinions regarding impact of achondroplasia on health-related quality of life and long-term effects of vosoritide: A modified Delphi study |
|
|
|
|
|
|
|
|
|
| eP209: Considering genetic disorders in premature individuals: YY1-related disorder in child born at 27 weeks gestation |
|
|
|
|
|
|
|
|
|
| eP210: A rare case of familial syndromic intellectual disability: First reported Portuguese patients |
|
|
|
|
|
|
|
|
|
| eP211: Incidental cutaneous tumor regression in an adult with NF1 on MEKinist monotherapy |
|
|
|
|
|
|
|
|
|
| eP212: Safety, β-Sarcoglycan expression, and functional outcomes from systemic gene transfer of rAAVrh74.MHCK7.hSGCB in LGMD2E/R4 |
|
|
|
|
|
|
|
|
|
| eP216: An unexpected diagnosis of RIDDLE syndrome and possible TUBGCP6-related disorder amidst controversial parental consanguinity |
|
|
|
|
|
|
|
|
|
| eP217: Ophthalmology genetics clinic in the times of COVID-19: A hybrid model |
|
|
|
|
|
|
|
|
|
| eP218: A novel FGFR2 variant in a family with a spectrum of anterior segment anomalies |
|
|
|
|
|
|
|
|
|
| eP220: Expanding the phenotypic spectrum of COLEC10-related 3MC syndrome: A glimpse into COLEC10-related 3MC syndrome in the Ashkenazi Jewish population |
|
|
|
|
|
|
✓ |
|
Ashkenazi Jewish population |
| eP221: Increased expression of ZFPM2 bypasses SRY to drive 46,XX testicular development: A new mechanism of 46,XX DSD |
|
|
|
|
|
|
|
|
|
| eP224: SMAD4-related juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome presenting as metastatic adenocarcinoma of the colon in a teenager – A case report |
|
|
|
|
|
|
|
|
|
| eP229: A case report of a complex chromosome 8 rearrangement with partial monosomy of 8p and partial trisomy of 8q |
|
|
|
|
|
|
|
|
|
| eP230: The effects of early androgen therapy on behavior in boys with 47,XXY under 6 years old |
|
|
|
|
|
|
|
|
|
| eP231: Ophthalmic findings associated with NEDD4L-related disorder: Novel finding in a patient and review of literature |
|
|
|
|
|
|
|
|
|
| eP233: Development and optimization of a clinical support algorithm for rapid identification of diagnostic germline variants |
|
|
|
|
|
|
|
|
|
| eP236: TeleKidSeq: Incorporating telehealth into clinical care of children from diverse backgrounds undergoing clinical genome sequencing |
|
|
|
|
|
|
|
|
|
| eP237: Clinical correlates, diagnosis, and management of sleep-disordered breathing in young children with Down syndrome |
|
|
|
|
|
|
|
|
|
| eP241: Incidental finding of autosomal recessive juvenile Parkinson disease-2 in chromosome 17q12 microduplication female infant |
|
|
|
|
|
|
|
|
|
| eP242: Analytical validation of a PCR/CE assay that phases SNPs with CAG-expanded alleles for selecting Huntington disease patients for allele-selective treatments |
|
|
|
|
|
|
|
|
|
| eP243: A novel variant in MORC2 associated with pigmentary retinopathy, short stature, microcephaly and white matter abnormalities |
|
|
|
|
|
|
|
|
|
| eP244: Rapid exome sequencing influences acute and long-term management of critically unwell children and their families |
|
|
|
|
|
|
|
|
|
| eP247: Pathogenic variant in valosin-containing protein causing inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia |
|
|
|
|
|
|
|
|
|
| eP250: Molecular findings in patients with atypical Sturge-Weber syndrome |
|
|
|
|
|
|
|
|
|
| eP251: Vascular anomalies in patients with Maffucci syndrome |
|
|
|
|
|
|
|
|
|
| eP252: A multidisciplinary endocrine-genetic obesity clinic for children: Diagnostic utility and insights |
|
|
|
|
|
|
|
|
|
| eP253: Incidence of miscarriages and recurrent miscarriages in women with children with 47,XXY, 48,XXXY, or 49,XXXXY |
|
|
|
|
|
|
|
|
|
| eP255: Proposition of a novel RASopathy mediated by variants in ARF1 |
|
|
|
|
|
|
|
|
|
| eP259: A phase 1/2 trial of AXO-AAV-GM1 gene therapy for the treatment of infantile- and juvenile-onset GM1 gangliosidosis |
|
|
|
|
|
|
|
|
|
| eP260: Expanding cohort of individuals with p.V142I homozygous alterations suggests presentation onset similar to heterozygotes |
|
|
|
|
|
|
|
|
|
| eP261: The spectrum of CFTR and PRSS1 pathogenic variants in chronic pancreatitis |
|
|
|
|
|
|
|
|
|
| eP262: De novo heterozygous variant in the RAB11B gene presenting with combined cardiac defect and neurodevelopmental disorder: A case report |
|
|
|
|
|
|
|
|
|
| eP263: A pathogenic deletion at 13q32.1q33.1 presenting with bilateral sensorineural hearing loss and pigmentation anomalies, mimicking Waardenburg syndrome |
|
|
|
|
|
|
|
|
|
| eP264: Genotype-phenotype correlation analysis and therapeutic development using a patient stem cell-derived disease model of Wolfram syndrome |
|
|
|
|
|
|
|
|
|
| eP266: Associations between height and Health-Related Quality of Life (HRQoL) and functional independence in children with achondroplasia |
|
|
|
|
|
|
|
|
|
| eP267: De novo COL11A1 and COL9A2 variants corresponding to Stickler syndrome phenotype |
|
|
|
|
|
|
|
|
|
| eP270: Incorporating genetic services into adult kidney disease care |
|
|
|
|
|
|
|
|
|
| eP271: Bi-allelic loss of function variant of the ACTG2 gene that proposes a potential novel mechanism for visceral myopathies |
|
|
|
|
|
|
|
|
|
| eP273: The critical role of NDF2 domain in FMR1 supported by a novel variant in two brothers with intellectual disability |
|
|
|
|
|
|
|
|
|
| eP274: Frequency of Bardet-Biedl syndrome and Alström syndrome gene variants in a cohort with early-onset obesity |
|
|
|
|
|
|
|
|
|
| eP275: Quality of life in patients with Bardet-Biedl syndrome in a setmelanotide phase 3 trial |
|
|
|
|
|
|
|
|
|
| eP277: Exploring the landscape of genetics patents in the United States from 2005 to 2020 |
|
|
|
|
|
|
|
|
|
| eP280: Continued improvement in adults with acid sphingomyelinase deficiency after 2 years of olipudase alfa in the ASCEND placebo-controlled trial |
|
|
|
|
|
|
|
|
|
| eP281: SeqFirst-neo: Improving access equity for a precise genetic diagnosis in the NICU |
|
|
|
|
|
|
|
|
|
| eP284: Should Ehlers-Danlos syndrome be considered a spectrum? A case report in supporting of the evidence |
|
|
|
|
|
|
|
|
|
| eP286: Genome-to-treatment: A system to guide the acute management of genetic disorders in children |
|
|
|
|
|
|
|
|
|
| eP288: Genomic characterization of a TP53 tandem duplication in a pediatric patient with Li-Fraumeni syndrome |
|
|
|
|
|
|
|
|
|
| eP291: Disease characterization in sodium-potassium ATPases by reverse genetics in humans |
|
|
|
|
|
|
|
|
|
| eP293: Patient satisfaction with telehealth genetic counseling across multiple subspecialties |
|
|
|
|
|
|
|
|
|
| eP294: Return of genome sequencing results in ostensibly healthy COVID-19 positive individuals: GENCOV Study Canada |
|
|
|
|
|
|
|
|
|
| eP295: Barriers to uptake of genetic services in families of pediatric hypertrophic cardiomyopathy patients |
|
|
|
|
|
|
|
|
|
| eP297: Overview of pediatric genetic counseling clinic models and genetic counselors' perceptions of them |
|
|
|
|
|
|
|
|
|
| eP299: Genetics adviser: The development and usability testing of a new patient-centered digital health application to support clinical genomic testing |
|
|
|
|
|
|
|
|
|
| eP300: Parent attitudes and perceptions after receiving Fragile X premutation results in the Early Check Newborn Screening Pilot Study |
|
|
|
|
|
|
|
|
|
| eP308: Factors associated with acquisition of inherited cancer knowledge after viewing a web-based educational tool among Black women with breast cancer |
|
|
|
|
|
|
|
|
|
| eP311: Diagnostic testing for Beckwith-Wiedemann syndrome/Russell-Silver syndrome: The GGC experience |
|
|
|
|
|
|
|
|
|
| eP313: Too few or too many? Variant reporting burden and diagnostic comparisons of an extensive gene panel with exome-sequencing in immunodeficiency |
|
|
|
|
|
|
|
|
|
| eP314: Rare unbalanced complex chromosomal rearrangement in a case of infertility: Insight into the 8p23.1 duplication syndrome |
|
|
|
|
|
|
|
|
|
| eP315: Development of an in-house long read sequencing clinical pharmacogenetic panel |
|
|
|
|
|
|
|
|
|
| eP321: Extending and adapting the functions of genetic laboratories in the continuing COVID pandemic–challenges and successes |
|
|
|
|
|
|
|
|
|
| eP322: Comparison of genetic ancestry to self-reported ethnicity and impact upon residual risk following expanded carrier screening |
|
|
|
|
|
|
|
|
|
| eP325: Medically actionable DNA variation from the GENCOV COVID-19 Genome Sequencing Study |
|
|
|
|
|
|
|
|
|
| eP326: Genome sequencing reveals BHLHA9 gene duplication as cause of multi-generational split-hand/foot malformation with long bone deficiency |
|
|
|
|
|
|
|
|
|
| eP327: A quantitative trait GWAS on lens thickness identifies risk loci on PTPRM in the narrow-angle individuals anatomically susceptible to PACG |
|
|
|
|
|
|
|
|
|
| eP328: Establishing droplet digital PCR method for assessing mitochondrial DNA content in muscle |
|
|
|
|
|
|
|
|
|
| eP329: Genome sequencing uncovers molecular cause in a case with epileptic encephalopathy |
|
|
|
|
|
|
|
|
|
| eP330: Mosaicism for SMARCB1 or LZTR1 variants in patients with schwannomatosis in the UAB cohort |
|
|
|
|
|
|
|
|
|
| eP331: Next-generation sequencing testing in identification and differential diagnosis of hereditary anemia due to erythrocyte membrane disorders, enzymopathies and related disorders |
|
|
|
|
|
|
|
|
|
| eP332: The importance of parental sequencing depth in the setting of rapid genome sequencing |
|
|
|
|
|
|
|
|
|
| eP334: Optical genome mapping workflow for constitutional genomic structural and copy number variation and analysis |
|
|
|
|
|
|
|
|
|
| eP335: Genetic testing for APOB, LDLR, PCSK9, and LDLRAP1 suggest that FH testing may be underutilized |
|
|
|
|
|
|
|
|
|
| eP336: A tale of two Hbs: DNA sequencing and hemoglobin electrophoresis |
|
|
|
|
|
|
|
|
|
| eP337: Rapid Genome Sequencing (rGS) as first tier test for critically ill children with suspected genetic etiology |
|
|
|
|
|
|
|
|
|
| eP338: Efficacy of next generation sequencing data reanalysis in unsolved cases with suspected Mendelian disorders: A systematic review and meta-analysis |
|
|
|
|
|
|
|
|
|
| eP339: Ending the diagnostic odyssey: De novo mosaic pathogenic 2,123 bp deletion in CDKL5 identified on genome sequencing |
|
|
|
|
|
|
|
|
|
| eP341: The full (mutation) picture: One-third of patients with Fragile X syndrome present with neurodevelopmental disorders without dysmorphism or family history |
|
|
|
|
|
|
|
|
|
| eP345: Community data-driven approach for generating cross-ethnic population carrier screening panel |
|
|
|
|
|
|
|
|
|
| eP346: The +5 position of the donor splice site and its role in genetic disorders |
|
|
|
|
|
|
|
|
|
| eP348: Human Pangenome Reference Consortium Coordinating Center |
|
|
|
|
|
|
|
|
|
| eP352: Systematic exploration of mosaic variants detected in blood samples from a primary immunodeficiency cohort referred for research exome sequencing |
|
|
|
|
|
|
|
|
|
| eP353: Testing for Y chromosome in Turner syndrome |
|
|
|
|
|
|
|
|
|
| eP354: A systematic approach for applying disease-specific phenotype in clinical variant interpretation |
|
|
|
|
|
|
|
|
|
| eP356: Exome sequencing expands the sensitivity and specificity of identification of sequence variants and CNVs in phenotypic females with DSD |
|
|
|
|
|
|
|
|
|
| eP357: Molecular diagnosis of Facioscapulohumeral Muscular Dystrophy (FSHD) using optical genome mapping |
|
|
|
|
|
|
|
|
|
| eP358: Genetic findings in a cohort of patients with pulmonary arterial hypertension referred for NGS panel testing |
|
|
|
|
|
|
|
|
|
| eP359: Diagnostic yield of genetic testing in an unselected cohort of patients with congenital heart disease |
|
|
|
|
|
|
|
|
|
| eP360: Exome analysis of prenatal and postnatal cases referred with skeletal dysplasia-overview of phenotypic and genomic and findings |
|
|
|
|
|
|
|
|
|
| eP365: Identification of a novel intragenic inversion of DMD exons 18 to 21 in a male with Duchenne muscular dystrophy |
|
|
|
|
|
|
|
|
|
| eP366: A comprehensive study of E200K genetic Creutzfeldt Jakob disease cases; effects of codon 129 polymorphism |
|
|
|
|
|
|
|
|
|
| eP368: A streamlined process for assessing the strength of a relationship between a gene and specific disease |
|
|
|
|
|
|
|
|
|
| eP375: Technical performance of a 455-gene preventative genomics assay |
|
|
|
|
|
|
|
|
|
| eP377: Enabling single-platform testing and carrier screening of the FMR1, SMN1/2, and CFTR gene trio |
|
|
|
|
|
|
|
|
|
| eP379: Optical genome mapping for high throughput analysis of repeat expansion disorders |
|
|
|
|
|
|
|
|
|
| eP380: Sequencing of entire 2.2 MB DMD gene facilitates diagnostic testing and aids selection of patients for therapeutic intervention |
|
|
|
|
|
|
|
|
|
| eP385: Interpretation of SNP-based NIPS data in the context of heteropaternal twins |
|
|
|
|
|
|
|
|
|
| eP386: Cystic fibrosis 165 pathogenic variants genotyping by MassARRAY |
|
|
|
|
|
|
|
|
|
| eP391: Optical genome mapping for constitutional postnatal SV, CNV, and repeat array sizing: A multi-site clinical study |
|
|
|
|
|
|
|
|
|
| eP394: Investigation and functional characterization of genomic signatures in congenital muscular dystrophy and congenital myopathy patients from India |
|
|
|
|
|
|
|
|
|
| eP396: Collaborative efforts between clinical genetics, cytogenetics, and neonatology improve genetic testing practices in the NICU |
|
|
|
|
|
|
|
|
|
| eP399: Characterizing molecular diagnostic findings from next-generation sequencing panel testing for individuals with suspected congenital hypothyroidism or resistance to thyroid hormone |
|
|
|
|
|
|
|
|
|
| eP402: Partial trisomy of chromosome 22 mediated by chromoanasynthesis in an 8-month-old male |
|
|
|
|
|
|
|
|
|
| eP403: Finding merit in impurity: Designing a cost-effective workflow for saliva genome sequencing |
|
|
|
|
|
|
|
|
|
| eP405: Clinical application of 24-hour ultra-rapid genome sequencing in a critically ill neonate |
|
|
|
|
|
|
|
|
|
| eP408: Prioritizing variant reanalysis based on ClinVar discrepancies can reduce the number of uncertain interpretations |
|
|
|
|
|
|
|
|
|
| eP410: De novo missense variants in DDX39B cause a novel syndrome characterized by neurodevelopmental delay, short stature and congenital hypotonia |
|
|
|
|
|
|
|
|
|
| eP413: Type II cat eye syndrome in a newborn with intrauterine growth retardation and echogenic intracardiac focus during pregnancy |
|
|
|
|
|
|
|
|
|
| eP414: Diagnostic yield and clinical utility of nephrolithiasis and primary hyperoxaluaria sequencing panels |
|
|
|
|
|
|
|
|
|
| eP415: Team-based genome diagnostics made possible with intuitive web-based iobio tools |
|
|
|
|
|
|
|
|
|
| eP418: Enabling reclassification of missense variants in PKD1/2 – the power of a commercial laboratory database |
|
|
|
|
|
|
|
|
|
| eP423: Ethical considerations in a case of non-paternity of a deceased neonate identified through genome sequencing |
|
|
|
|
|
|
|
|
|
| eP424: Newborn screening is associated with decreased parental depression and stress compared to clinical diagnosis: Results from a cross-sectional survey |
|
|
|
|
|
|
|
|
|
| eP426: Utilization of the ACMG ACT sheets and algorithms on the ACMG website |
|
|
|
|
|
|
|
|
|
| eP430: Genetics professionals’ perspectives on the reporting of Variants of Uncertain Significance (VUS): Should they always be reported? |
|
|
|
|
|
|
|
|
|
| eP431: Applying the clinician-reported genetic testing utility InDEx (C-GUIDE) to genome sequencing |
|
|
|
|
|
|
|
|
|
| eP436: Genetics preparedness among frontline clinicians and the demand for genetics providers: The Wisdom Paradox |
|
|
|
|
|
|
|
|
|
| eP439: A survey on the satisfaction of standard primary care residency training in genetics education |
|
|
|
|
|
|
|
|
|
| eP443: Fetal fraction amplification within NIPS enables detection of clinically-relevant genome-wide copy-number variants to 1Mb resolution |
|
|
|
|
|
|
|
|
|
| eP445: Fatty acid oxidation disorders and acute fatty liver of pregnancy- is it always the LCHAD deficiency 1528G>C variant? |
|
|
|
|
|
|
|
|
|
| eP452: Diagnostic yield and outcomes of NGS testing in pregnancies with a fetal structural anomaly |
|
|
|
|
|
|
|
|
|
| eP456: Heterozygous deletion of the VEGFC gene in 4q34.3 is associated with Milroy-Like lymphedema: First prenatal case report |
|
|
|
|
|
|
|
|
|
| eP459: Rare clinical gene variant of SOX9: Acampomelic campomelic dysplasia |
|
|
|
|
|
|
|
|
|
| eP460: Diagnostic dilemma in a case of suspected fetal skeletal dysplasia |
|
|
|
|
|
|
|
|
|
| eP461: Barriers to prenatal genetic testing for male partners at a Los Angeles County public teaching hospital |
|
|
|
|
|
|
|
|
|
| eP462: Detection of clinically relevant exonic copy number changes in fetuses by chromosomal microarray analysis |
|
|
|
|
|
|
|
|
|
| eP463: Inconclusive Duchenne Muscular Dystrophy (DMD) carrier screening and atypical SNP-based NIPS sex chromosomes analysis suggest maternal sex chromosome abnormality |
|
|
|
|
|
|
|
|
|
| eP464: No chromosome abnormality left behind: When karyotype following positive cfDNA screening does not tell the full story |
|
|
|
|
|
|
|
|
|
| eP467: Prenatal genetic testing can lead to (almost) self-fulfilling prophecy: Diastrophic dysplasia as an example |
|
|
|
|
|
|
|
|
|
| eP470: Racial and ethnic disparities in universal expanded carrier screening completion in an inner city population |
|
|
|
|
|
|
|
|
|
| eP471: The role of clinical exome sequencing in genetic diagnosing of skeletal dysplasia in fetus detected by prenatal ultrasound in Vietnam |
|
|
|
|
|
|
|
|
|
| eP472: Deriving risk estimates for balanced rearrangement carriers utilizing PGT-SR data |
|
|
|
|
|
|
|
|
|
| eP476: Applying implementation science to support the success of a precision health initiative in a learning health system |
|
|
|
|
|
|
|
|
|
| eP477: A classifier prioritizing exome and genome sequencing cases for re-analysis |
|
|
|
|
|
|
|
|
|
| eP479: Primary care providers’ use of genetic services in the Southeast United States: Barriers, facilitators, and strategies |
|
|
|
|
|
|
|
|
|
| eP481: Advancing genetic disease understanding and improving health outcomes: The LTFU-Cares and LTFU-Check Initiative |
|
|
|
|
|
|
|
|
|
| eP483: Integrating family health history screening and genetic testing via electronic health record with clinical decision support in routine mammography screening |
|
|
|
|
|
|
|
|
|
| eP486: Demonstrating the utility of consumer initiated genetic testing: The identification of a family with vascular Ehlers-Danlos syndrome |
|
|
|
|
|
|
|
|
|
| eP487: Universal newborn screening of congenital cytomegalovirus using dried blood spots and qPCR |
|
|
|
|
|
|
|
|
|
| eP488: Patient-centric adaptations for pheNIX clinical trial evaluating HMI-102 gene therapy in adults with PKU in the era of COVID-19 |
|
|
|
|
|
|
|
|
|
| eP489: Exploring engagement and uptake of a comprehensive family history-based cancer risk assessment tool |
|
|
|
|
|
|
|
|
|
| eP490: A united front on tackling a pandemic – the true value of industry and government partnerships |
|
|
|
|
|
|
|
|
|
| eP493: Population genetic screening study participants intend to share test results with family members |
|
|
|
|
|
|
|
|
|
| eP496: Essential workforce for a successful precision medicine program |
|
|
|
|
|
|
|
|
|
| eP501: Family engagement within the genetics delivery system: Family perspective |
|
|
|
|
|
|
|
|
|
| eP503: Variables associated with parental decision to receive Fragile X premutation results after newborn screening for Fragile X syndrome |
|
|
|
|
|
|
|
|
|
| eP505: Physicians’ attitudes about integrating genetic testing into primary care as an elective clinical service: The Sanford Health experience |
|
|
|
|
|
|
|
|
|
| eP507: Patients’ reasons for genetic testing refusal in cancer evaluations: An analysis of the literature and opportunities to educate |
|
|
|
|
|
|
|
|
|
| eP509: Implementation and impact of dedicated inpatient genetic counselors in a children’s hospital |
|
|
|
|
|
|
|
|
|
| eP512: Identifying clinical and psychological factors associated with genomics-related outcomes in a centralized sequencing protocol |
|
|
|
|
|
|
|
|
|
| eP514: Extending cascade screening using genealogy, DTC genetics and social media – the ConnectMyVariant exploratory pilot study |
|
|
|
|
|
|
|
|
|
| eP515: Family-level utility of pediatric genomic sequencing: A qualitative analysis and attribute framework |
|
|
|
|
|
|
|
|
|
| eP520: Screening results in 186 any-health-status adults in primary care clinics receiving clinical NGS for 431 health risk and recessive genes |
|
|
|
|
|
|
|
|
|
| OP003: Characterization of variants of uncertain significance in very long-chain acyl-CoA dehyrogenase identified through newborn screening |
|
|
|
|
|
|
|
|
|
| OP004: Newly identified disorder of copper metabolism caused by variants in CTR1, a high-affinity copper transporter |
|
|
|
|
|
|
|
|
|
| OP005: AT-007 significantly reduces toxic galactitol in ACTION-galactosemia kids - the 1st therapeutic interventional clinical trial in children with classic galactosemia |
|
|
|
|
|
|
|
|
|
| OP007: Cardiolipin remodeling deregulation and mitochondrial bioenergetics alterations in trifunctional protein (TFP) deficiency |
|
|
|
|
|
|
|
|
|
| OP008: Implementation of a universal somatic tumor screening program for hereditary cancer in patients with advanced cancer in a large HMO |
|
|
|
|
|
|
|
|
|
| OP009: Feasibility of a traceback approach to facilitate genetic testing in the Genetic Risk Analysis in Ovarian Cancer (GRACE) study |
|
|
|
|
|
|
|
|
|
| OP010: Germline genetic testing outcomes in a cohort of pediatric patients with hematological malignancies or primary immunodeficiencies undergoing bone marrow transplantation |
|
|
|
|
|
|
|
|
|
| OP013: Landscape of germline pathogenic variants in cancer susceptibility genes in patients with sarcoma |
|
|
|
|
|
|
|
|
|
| OP019: A tertiary care clinical sequencing program for patients with suspected immune defects: Results from the first 1000 families |
|
|
|
|
|
|
|
|
|
| OP021: Vosoritide for children with achondroplasia: Growth velocity and pubertal milestones |
|
|
|
|
|
|
|
|
|
| OP023: A clinical scoring system for early onset (neonatal) Marfan syndrome |
|
|
|
|
|
|
|
|
|
| OP027: Patient-initiated genetic counseling through an online hereditary cancer questionnaire |
|
|
|
|
|
|
|
|
|
| OP029: Genetic updates returned by GenomeConnect, the ClinGen patient registry: A pilot study of participant experience |
|
|
|
|
|
|
|
|
|
| OP031: The emotional experience of hemophilia heterozygote women: Average maternal guilt, effective coping strategies, and resilience within the hemophilia community |
|
|
|
|
|
|
|
|
|
| OP033: An integrated multiomic panel as an excellent tool for the genetic diagnosis of metabolic diseases: Our first 3,720 patients |
|
|
|
|
|
|
|
|
|
| OP034: Evaluation of the 2019 ACMG-ClinGen guidelines for interpretation of copy-number variants with borderline classifications at an academic clinical diagnostics laboratory |
|
|
|
|
|
|
|
|
|
| OP038: Novel whole methylome automated data analysis tool for investigation of unsolved diagnostic odyssey cases |
|
|
|
|
|
|
|
|
|
| OP042: A matter of opinion: An exploratory study of parental attitudes towards newborn screening for conditions of varying onset and treatability |
|
|
|
|
|
|
|
|
|
| OP043: The evolving attitude towards privacy and security of personal genomic data |
|
|
|
|
|
|
|
|
|
| OP045: Status of training in genomics for clinical informatics and informatics for genomic medicine |
|
|
|
|
|
|
|
|
|
| OP046: Stigma manifestations impact patient and clinical outcomes in cardiogenetic care: “Sometimes it’s depressing. Sometimes I feel like giving up.” |
|
|
|
|
|
|
|
|
|
| OP048: The impact of route of delivery on surgical morbidity in fetuses affected by achondroplasia: A multicenter retrospective study |
|
|
|
|
|
|
|
|
|
| OP050: Cell-free DNA fetal fraction and adverse obstetric outcomes in twin pregnancy |
|
|
|
|
|
|
|
|
|
| OP053: Barriers to completion of expanded carrier screening in an inner city population |
|
|
|
|
|
|
|
|
|
| OP056: ScreenPlus pilot newborn screening: recruitment and engagement findings from the first 300 consented infants |
|
|
|
|
|
|
|
|
|
| OP057: Implementation of universal Lynch syndrome tumor screening programs – A comparison of health care systems with and without programs |
|
|
|
|
|
|
|
|
|
| OP058: 2021 genetics policies in state Medicaid programs |
|
|
|
|
|
|
|
|
|
| eP422: Diagnostic rate of genetic testing in a pediatric research cohort with clinical insurance denials |
|
|
|
|
|
|
|
|
|
| eP442: Patients’ reaction to and interpretation of secondary genomic findings with limited or no medical actionability |
|
|
|
|
|
|
|
|
|
| OP024: Discovery and therapeutic implications of pathogenic retroelements in neurodegenerative diseases |
|
|
|
|
|
|
|
|
|
| OP047: Timely diagnosis of mucopolysaccharidosis: Results from an innovative physician education program with a national outreach |
|
|
|
|
|
|
|
|
|
| OP054: Chromosomal microarray analysis for open neural tube defect: The prevalence of significant results and implications on in utero repair |
|
|
|
|
|
|
|
|
|
| OP059: Clinical impact of a targeted pharmacogenomic assessment within a cohort of individuals with suspected inborn errors of immunity |
|
|
|
|
|
|
|
|
|
| Editorial Board |
|
|
|
|
|
|
|
|
|
| Dominant negative effects of SCN5A missense variants |
|
|
|
|
|
|
|
|
|
| Genomic answers for children: Dynamic analyses of >1000 pediatric rare disease genomes |
|
|
|
|
|
|
|
|
|
| Laboratory-related outcomes from integrating an accessible delivery model for hereditary cancer risk assessment and genetic testing in populations with barriers to access |
|
|
|
|
|
|
|
|
|
| Genome Alert!: A standardized procedure for genomic variant reinterpretation and automated gene–phenotype reassessment in clinical routine |
|
|
|
|
|
|
|
|
|
| Perspectives of United States neonatologists on genetic testing practices |
|
|
|
|
|
|
|
|
|
| Expanding the phenotypic spectrum of ARCN1-related syndrome |
|
|
|
|
|
|
|
|
|
| Editorial Board |
|
|
|
|
|
|
|
|
|
| Masthead |
|
|
|
|
|
|
|
|
|
| Table of Contents |
|
|
|
|
|
|
|
|
|
| Response to Righetti et al |
|
|
|
|
|
|
|
|
|
| Cost-effectiveness of population-wide genomic screening for Lynch syndrome in the United States |
|
|
|
|
|
|
|
|
|
| Integration of stakeholder engagement from development to dissemination in genomic medicine research: Approaches and outcomes from the CSER Consortium |
|
|
|
|
|
|
|
|
|
| Pancreatic cancer risk to siblings of probands in bilineal cancer settings |
|
|
|
|
|
|
|
|
|
| Trio genome sequencing for developmental delay and pediatric heart conditions: A comparative microcost analysis |
|
|
|
|
|
|
|
|
|
| MECOM-related disorder: Radioulnar synostosis without hematological aberration due to unique variants |
|
|
|
|
|
|
|
|
|
| The reckoning: The return of genomic results to 1444 participants across the eMERGE3 Network |
|
|
|
|
|
|
|
|
|
| Response to Chambuso et al |
|
|
|
|
|
|
|
|
|
| Universal tumor screening in a population with MSH6- and PMS2-associated Lynch syndrome |
|
|
|
|
|
|
|
|
|
| Worldwide prevalence of Lynch syndrome in patients with colorectal cancer: Systematic review and meta-analysis |
|
|
|
|
|
|
|
|
|
| Response to Leidi et al |
|
|
|
|
|
|
|
|
|
| Is faster better? An economic evaluation of rapid and ultra-rapid genomic testing in critically ill infants and children |
|
|
|
|
|
|
|
|
|
| Correspondence on “Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database” by Dominguez-Valentin et al |
|
|
|
|
|
|
|
|
|
| Correspondence on “Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG)” by |
|
|
|
|
|
|
|
|
|
| Loss-of-function variants in KLF4 underlie autosomal dominant palmoplantar keratoderma |
|
|
|
|
|
|
|
|
|
| Correspondence on “Expanded phenotype of AARS1-related white matter disease” by Helman et al |
|
|
|
|
|
|
|
|
|
| Clinical pharmacogenomic testing and reporting: A technical standard of the American College of Medical Genetics and Genomics (ACMG) |
|
|
|
|
|
|
|
|
|
| Measurement of lysosomal enzyme activities: A technical standard of the American College of Medical Genetics and Genomics (ACMG) |
|
|
|
|
|
|
|
|
|
| Centers for Mendelian Genomics: A decade of facilitating gene discovery |
|
|
|
|
|
|
|
|
|
| Return of genomic results does not motivate intent to participate in research for all: Perspectives across 22 countries |
|
|
|
|
|
|
|
|
|
| Expanding the genotype and phenotype spectrum of SYT1-associated neurodevelopmental disorder |
|
|
|
|
|
|
|
|
|
| Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Varia |
|
|
|
|
|
|
|
|
|
| Correspondence on “Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: A practice resource of the American College of Medical Genetics and Genomics (ACMG)” by |
|
|
|
|
|
|
|
|
|
| Diagnostic sequencing to support genetically stratified medicine in a tertiary care setting |
|
|
|
|
|
|
|
|
|
| Masthead |
|
|
|
|
|
|
|
|
|
| Table of Contents |
|
|
|
|
|
|
|
|
|
| Editorial Board |
|
|
|
|
|
|
|
|
|
| A practical guide to interpreting germline variants that drive hematopoietic malignancies, bone marrow failure, and chronic cytopenias |
|
|
|
|
|
|
|
|
|
| CDK13-related disorder: Report of a series of 18 previously unpublished individuals and description of an epigenetic signature |
|
|
|
|
|
|
|
|
|
| TRAPPC9-CDG: A novel congenital disorder of glycosylation with dysmorphic features and intellectual disability |
|
|
|
|
|
|
|
|
|
| Molecular characterization and investigation of the role of genetic variation in phenotypic variability and response to treatment in a large pediatric Marfan syndrome cohort |
|
|
|
|
|
|
|
|
|
| Self-rated family health history knowledge among All of Us program participants |
|
|
|
|
|
|
|
|
|
| Re-analysis of genomic data: An overview of the mechanisms and complexities of clinical adoption |
|
|
|
|
|
|
|
|
|
| Testing and extending strategies for identifying genetic disease–related encounters in pediatric patients |
|
|
|
|
|
|
|
|
|
| Identification of 4 novel human ocular coloboma genes ANK3, BMPR1B, PDGFRA, and CDH4 through evolutionary conserved vertebrate gene analysis |
|
|
|
|
|
|
|
|
|
| Genetic Determinants of Sudden Unexpected Death in Pediatrics |
|
|
|
|
|
|
|
|
|
| Biallelic p.V37I variant in GJB2 is associated with increasing incidence of hearing loss with age |
|
|
|
|
|
|
|
|
|
| DNA methylation episignature in Gabriele-de Vries syndrome |
|
|
|
|
|
|
|
|
|
| Table of Contents |
|
|
|
|
|
|
|
|
|
| Editorial Board |
|
|
|
|
|
|
|
|
|
| Masthead |
|
|
|
|
|
|
|
|
|
| The rare disease neurofibromatosis 1 as a source of hereditary economic inequality: Evidence from Finland |
|
|
|
|
|
|
|
|
|
| Evaluating the impact of in silico predictors on clinical variant classification |
|
|
|
|
|
|
|
|
|
| Increasing inclusivity in precision medicine research: Views of deaf and hard of hearing individuals |
|
|
|
|
|
|
|
|
|
| Response to Dwyer et al |
|
|
|
|
|
|
|
|
|
| Correspondence on “Ensuring best practice in genomics education and evaluation: Reporting item standards for education and its evaluation in genomics (RISE2 Genomics)” by Nisselle et al |
|
|
|
|
|
|
|
|
|
| Points to consider to avoid unfair discrimination and the misuse of genetic information: A statement of the American College of Medical Genetics and Genomics (ACMG) |
|
|
|
|
|
|
|
|
|
| Stewardship of patient genomic data: A policy statement of the American College of Medical Genetics and Genomics (ACMG) |
|
|
|
|
|
|
|
|
|
| Polygenic risk scores for prediction of breast cancer risk in Asian populations |
|
|
|
|
|
|
|
|
|
| Phase 3 trial of lumasiran for primary hyperoxaluria type 1: A new RNAi therapeutic in infants and young children |
|
|
|
|
|
|
|
|
|
| A systematic review of the methodological quality of economic evaluations in genetic screening and testing for monogenic disorders |
|
|
|
|
|
|
|
|
|
| Response to Cueto-González et al |
|
|
|
|
|
|
|
|
|
| Structural mapping of GABRB3 variants reveals genotype–phenotype correlations |
|
|
|
|
|
|
|
|
|
| Correspondence on “Loss-of-function and missense variants in NSD2 cause decreased methylation activity and are associated with a distinct developmental phenotype” by Zanoni et al |
|
|
|
|
|
|
|
|
|
| ImprintSeq, a novel tool to interrogate DNA methylation at human imprinted regions and diagnose multilocus imprinting disturbance |
|
|
|
|
|
|
|
|
|
| Identification and quantification of oligogenic loss-of-function disorders |
|
|
|
|
|
|
|
|
|
| The complexity of diagnosing rare disease: An organizing framework for outcomes research and health economics based on real-world evidence |
|
|
|
|
|
|
|
|
|
| Targeted BRCA1/2 population screening among Ashkenazi Jewish individuals using a web-enabled medical model: An observational cohort study |
|
|
|
|
|
|
✓ |
|
Ashkenazi Jewish |
| Interpretation and reporting of large regions of homozygosity and suspected consanguinity/uniparental disomy, 2021 revision: A technical standard of the American College of Medical Genetics and Genomi |
|
|
|
|
|
|
|
|
|
| Correspondence on “Exploring the motivations of research participants who chose not to learn medically actionable secondary findings about themselves” by Schupmann et al |
|
|
|
|
|
|
|
|
|
| Genetic testing in Non-Hispanic Black women with breast cancer treated within an equal-access healthcare system |
|
|
|
|
|
|
|
|
|
| DNA methylation episignature testing improves molecular diagnosis of Mendelian chromatinopathies |
|
|
|
|
|
|
|
|
|
| US private payers’ perspectives on insurance coverage for genome sequencing versus exome sequencing: A study by the Clinical Sequencing Evidence-Generating Research Consortium (CSER) |
|
|
|
|
|
|
|
|
|
| Cost-effectiveness of genome sequencing for diagnosing patients with undiagnosed rare genetic diseases |
|
|
|
|
|
|
|
|
|
| Standardized practices for RNA diagnostics using clinically accessible specimens reclassifies 75% of putative splicing variants |
|
|
|
|
|
|
|
|
|
| Children with genetic conditions in the United States: Prevalence estimates from the 2016-2017 National Survey of Children’s Health |
|
|
|
|
|
|
|
|
|
| Artificial intelligence (AI)-assisted exome reanalysis greatly aids in the identification of new positive cases and reduces analysis time in a clinical diagnostic laboratory |
|
|
|
|
|
|
|
|
|
| Reverse phenotyping facilitates disease allele calling in exome sequencing of patients with CAKUT |
|
|
|
|
|
|
|
|
|
| The Clinical Genome Resource (ClinGen) Familial Hypercholesterolemia Variant Curation Expert Panel consensus guidelines for LDLR variant classification |
|
|
|
|
|
|
|
|
|
| The splicing effect of variants at branchpoint elements in cancer genes |
|
|
|
|
|
|
|
|
|
| The Clinician-reported Genetic testing Utility InDEx (C-GUIDE): Preliminary evidence of validity and reliability |
|
|
|
|
|
|
|
|
|
| Performance of polygenic risk scores for cancer prediction in a racially diverse academic biobank |
|
|
|
|
|
|
|
|
|
| An innovative medical school curriculum to enhance exposure to genetics and genomics: Updates and outcomes |
|
|
|
|
|
|
|
|
|
| Phenotype based prediction of exome sequencing outcome using machine learning for neurodevelopmental disorders |
|
|
|
|
|
|
|
|
|
| Response to Timothé Ménard |
|
|
|
|
|
|
|
|
|
| Systematic review of outcomes in studies of reproductive genetic carrier screening: Towards development of a core outcome set |
|
|
|
|
|
|
|
|
|
| Improved provider preparedness through an 8-part genetics and genomic education program |
|
|
|
|
|
|
|
|
|
| Decision-making, attitudes, and understanding among patients and relatives invited to undergo genome sequencing in the 100,000 Genomes Project: A multisite survey study |
|
|
|
|
|
|
|
|
|
| Genetic heterogeneity of heritable ectopic mineralization disorders in a large international cohort |
|
|
|
|
|
|
|
|
|
| Implementation of fetal clinical exome sequencing: Comparing prospective and retrospective cohorts |
|
|
|
|
|
|
|
|
|
| Response to Shen et al. |
|
|
|
|
|
|
|
|
|
| Elucidating the clinical spectrum and molecular basis of HYAL2 deficiency |
|
|
|
|
|
|
|
|
|
| Response to McGurk et al |
|
|
|
|
|
|
|
|
|
| Quantifying evidence toward pathogenicity for rare phenotypes: The case of succinate dehydrogenase genes, SDHB and SDHD |
|
|
|
|
|
|
|
|
|
| Correspondence on “cost or price of sequencing? implications for economic evaluations in genomic medicine” by Grosse and Gudgeon |
|
|
|
|
|
|
|
|
|
| Novel loss-of-function variant in DENND5A impedes melanosomal cargo transport and predisposes to familial cutaneous melanoma |
|
|
|
|
|
|
|
|
|
| Stankiewicz-Isidor syndrome: expanding the clinical and molecular phenotype |
|
|
|
|
|
|
|
|
|
| Multiomics subtyping for clinically prognostic cancer subtypes and personalized therapy: A systematic review and meta-analysis |
|
|
|
|
|
|
|
|
|
| The relationship between performance on the medical genetics and genomics in-training and certifying examinations |
|
|
|
|
|
|
|
|
|
| Response to Clayton et al. |
|
|
|
|
|
|
|
|
|
| The training of future clinical geneticists: Evaluation and reflection on the ACMG Foundation for Genetic and Genomic Medicine Summer Genetics Scholars Program |
|
|
|
|
|
|
|
|
|
| The importance of automation in genetic diagnosis: Lessons from analyzing an inherited retinal degeneration cohort with the Mendelian Analysis Toolkit (MATK) |
|
|
|
|
|
|
|
|
|
| Retrospective analysis of a clinical exome sequencing cohort reveals the mutational spectrum and identifies candidate disease–associated loci for BAFopathies |
|
|
|
|
|
|
|
|
|
| The difficulties of broad data sharing in genomic medicine: Empirical evidence from diverse participants in prenatal and pediatric clinical genomics research |
|
|
|
|
|
|
|
|
|
| Predictors of low bone density and fracture risk in Loeys–Dietz syndrome |
|
|
|
|
|
|
|
|
|
| Loss-of-function variants in exon 4 of TAB2 cause a recognizable multisystem disorder with cardiovascular, facial, cutaneous, and musculoskeletal involvement |
|
|
|
|
|
|
|
|
|
| The comorbidity landscape of 47,XXX syndrome: A nationwide epidemiologic study |
|
|
|
|
|
|
|
|
|
| Suspected clonal hematopoiesis as a natural functional assay of TP53 germline variant pathogenicity |
|
|
|
|
|
|
|
|
|
| Correspondence on “ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)” by |
|
|
|
|
|
|
|
|
|
| KDM1A inactivation causes hereditary food-dependent Cushing syndrome |
|
|
|
|
|
|
|
|
|
| Pathogenic variants in RNPC3 are associated with hypopituitarism and primary ovarian insufficiency |
|
|
|
|
|
|
|
|
|
| Reevaluating the “right not to know” in genomics research |
|
|
|
|
|
|
|
|
|
| Addendum: Technical standards and guidelines: Molecular genetic testing for ultra-rare disorders |
|
|
|
|
|
|
|
|
|
| GM3 synthase deficiency in non-Amish patients |
|
|
|
|
|
|
|
|
|
| Precision medicine research with American Indian and Alaska Native communities: Results of a deliberative engagement with tribal leaders |
|
|
|
|
|
|
|
|
|
| Become an ambassador to recruit the next generation in genomic medicine |
|
|
|
|
|
|
|
|
|
| Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants |
|
|
|
|
|
|
|
|
|
| Digenic inheritance of STUB1 variants and TBP polyglutamine expansions explains the incomplete penetrance of SCA17 and SCA48 |
|
|
|
|
|
|
|
|
|
| Accurate assignment of disease liability to genetic variants using only population data |
|
|
|
|
|
|
|
|
|
| Risk of cancer in heterozygous relatives of patients with Fanconi anemia |
|
|
|
|
|
|
|
|
|
| Outcome of over 1500 matches through the Matchmaker Exchange for rare disease gene discovery: The 2-year experience of Care4Rare Canada |
|
|
|
|
|
|
|
|
|
| Heterogeneity in how women value risk-stratified breast screening |
|
|
|
|
|
|
|
|
|
| A guidelines-consistent carrier screening panel that supports equity across diverse populations |
|
|
|
|
|
|
|
|
|
| Variants in ADD1 cause intellectual disability, corpus callosum dysgenesis, and ventriculomegaly in humans |
|
|
|
|
|
|
|
|
|
| Correspondence on “Treatment of ARS deficiencies with specific amino acids” by Kok et al |
|
|
|
|
|
|
|
|
|
| Reanalysis of eMERGE phase III sequence variants in 10,500 participants and infrastructure to support the automated return of knowledge updates |
|
|
|
|
|
|
|
|
|
| The safety and efficacy of gene therapy treatment for monogenic retinal and optic nerve diseases: A systematic review |
|
|
|
|
|
|
|
|
|
| Correspondence on “Artificial intelligence–assisted phenotype discovery of fragile X syndrome in a population-based sample” by Movaghar et al |
|
|
|
|
|
|
|
|
|
| Consistent count region–copy number variation (CCR-CNV): an expandable and robust tool for clinical diagnosis of copy number variation at the exon level using next-generation sequencing data |
|
|
|
|
|
|
|
|
|
| Breast and prostate cancer risk: The interplay of polygenic risk, rare pathogenic germline variants, and family history |
|
|
|
|
|
|
|
|
|
| Genome sequencing as a first-line diagnostic test for hospitalized infants |
|
|
|
|
|
|
|
|
|
| The ACMG SF v3.0 gene list increases returnable variant detection by 22% when compared with v2.0 in the ClinSeq cohort |
|
|
|
|
|
|
|
|
|
| The opinions and experiences of people with intellectual disability regarding genetic testing and genetic medicine: A systematic review |
|
|
|
|
|
|
|
|
|
| Genome and RNA sequencing in patients with methylmalonic aciduria of unknown cause |
|
|
|
|
|
|
|
|
|
| Automated reanalysis application to assist in detecting novel gene–disease associations after genome sequencing |
|
|
|
|
|
|
|
|
|
| Quantifying prediction of pathogenicity for within-codon concordance (PM5) using 7541 functional classifications of BRCA1 and MSH2 missense variants |
|
|
|
|
|
|
|
|
|
| Motivations and concerns of patients considering participation in an implementation study of a hereditary cancer risk assessment program in diverse primary care settings |
|
|
|
|
|
|
|
|
|
| Diversity in cancer genomics research is a matter of equity and scientific discovery |
|
|
|
|
|
|
|
|
|
| Carrier screening in the Mexican Jewish community using a pan-ethnic expanded carrier screening NGS panel |
|
|
|
|
|
|
|
|
|
| Medical manifestations and health care utilization among adult MyCode participants with neurodevelopmental psychiatric copy number variants |
|
|
|
|
|
|
|
|
|